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Abstract 
Output measures used in the national accounts aspire to capture as comprehensively and accurately 
as possible the value that society places on everything produced by the economy. Given that 
economies produce heterogeneous products, some means of defining and valuing these is required 
so that a single aggregate measure of output can be constructed. 
 
For products traded in the market economy this is conceptually quite straightforward, but it requires 
the assumption that prices reflect marginal social values and equate to the marginal costs of 
ƉƌŽĚƵĐƚŝŽŶ ?&ŽƌƉƌŽĚƵĐƚƐĂŶĚƐĞƌǀŝĐĞƐŵĂĚĞĂǀĂŝůĂďůĞďǇƚŚĞ ‘Ŷon-ŵĂƌŬĞƚ ?ĞĐŽŶŽŵǇ ?ĞŶĐŽŵƉĂƐƐŝŶŐ
sectors such as defence, education and health systems, among others, the above assumption does 
not hold. People access and use the services provided by these sectors but rarely pay for them at 
point of use or, if they have to pay something out-of-pocket, it is usually subsidised. 
 
^Ž ?ĨŽƌ ‘ŶŽŶ-ŵĂƌŬĞƚ ?ƉƌŽĚƵĐƚƐ ?ƚǁŽǁĂǇƐŚĂǀĞďĞĞŶƉƌŽƉŽƐĞĚƚŽĐŽŶƐƚƌƵĐƚĂŶĞƋƵŝǀĂůĞŶƚŽƵƚƉƵƚ
measure: (1) to substitute information about the price of the output with its cost of production, 
making the assumption that marginal costs equate to marginal social values and (2) to describe and 
capture the characteristics of each product, recognising that products with more desirable 
characteristics are of greater value. In common parlance, this bundle of characteristics reflects the 
ŽǀĞƌĂůů ‘ƋƵĂůŝƚǇ ?ŽĨƚŚĞƉƌŽĚƵĐƚ ? 
 
A combination of these two general approaches has been adopted to assess the contribution of the 
English National Health Service (NHS) in the national accounts. Current practice in accounting for the 
quality of healthcare services makes use of routinely available information in order to capture the 
QALYs associated with treating patients, by combining information on survival rates, life expectancy 
and a measure of change in health status before and after treatment. The process of care delivery is 
captured by measures of treatment waiting times.  
 
This approach may overlook other important characteristics of the quality of healthcare. This review 
provides the conceptual framework needed to select potentially appropriate characteristics of 
healthcare outputs. To this end we evaluated three published sets of criteria developed by national 
bodies responsible for assessing healthcare system performance. We also sought the opinions of UK 
experts on quality expressed at a workshop. From this process seven criteria were established. We 
next reviewed two sources of quality indicators currently collected and reported for the English NHS: 
the NHS Outcomes Framework indicators and NHS Thermometer indicators. A schema, including 
indicator name and source, data source, time period covered, definitions and purpose, was 
developed for each of the indicators. Indicators were individually assessed by the research team, 
and one expert from the Department of Health and one from the Office for National Statistics in 
order to establish whether they met each of the identified criteria. Depending on the level of 
consensus among reviewers, a maximum of 17 indicators were short-listed for potential use as 
quality adjustors for NHS output, all of which are NHS Outcomes Framework indicators. 
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1. Introduction 
Output measures used in the national accounts aspire to capture as comprehensively and accurately 
as possible the value that society places on everything produced by the economy. Given that 
economies produce heterogeneous products, some means of defining and valuing these is required 
so that a single aggregate measure of output can be constructed. 
 
For products traded in the market economy (Mkt) this is conceptually quite straightforward, but it 
requires the assumption that prices reflect marginal social values and equate to the marginal costs 
of production. If this is accepted, output measurement reduces to a collection of information about 
the volume ሺݔሻ and price ሺ݌ሻ of each traded productሺ݆ ൌ  ? ǥ ܬሻ.  We can combine these to form the 
following aggregate measure of output ሺܻሻ for the sector ሺݏሻ in question: 
 ௦ܻெ௞௧ ൌ  ? ݔ௝݌௝௝           (1.1) 
 
To measure growth in output, the volumes of each product are compared across consecutive 
periods, holding prices constant. We can use either prices from the current or the base period. If 
using prices from the base period ሺ݌௝௧ିଵሻ  the Laspeyres index (L) of output growth is specified as: 
  ? ௦ܻ ?௅ெ௞௧ ൌ  ? ௫ೕ೟௣ೕ೟షభೕ ? ௫ೕ೟షభ௣ೕ೟షభೕ          (1.2) 
 
If current prices ሺ݌௝௧ሻ are used, the Paasche index (P) is specified as: 
  ? ௦ܻ ?௉ெ௞௧ ൌ  ? ௫ೕ೟௣ೕ೟ೕ ? ௫ೕ೟షభ௣ೕ೟ೕ          (1.3) 
 
There is a slight difference in the interpretation between the two indices. In the case of Laspeyres 
index, the individual can afford the same basket of products in the current period as in the base 
period. Conversely, with the Paasche index the assumption is that the individual could have afforded 
the same goods in the previous period as she can now.  
 
While these indices capture well the output in the market economy, there are many things produced 
by the economy for which consumers do not have to pay the full price. The  ‘ŶŽŶ-ŵĂƌŬĞƚ ?ĞĐŽŶŽŵǇ
(NMkt) encompasses those sectors which are funded, wholly or partially, through taxation. In most 
countries these typically include government, and the justice, police, defence, education and health 
systems, among others [1]. People access and use the services provided by these sectors but rarely 
pay for these services at point of use or, if they have to pay something out-of-pocket, it is usually 
subsidised.  
 
This means that the assumption we made about products traded in the market economy - that 
prices reflect marginal social values and equate to the marginal costs of production  W does not hold. 
While it may be possible to collect information about the volume of services provided, information 
on prices is unavailable. As a consequence, output measurement for non-market sectors is less 
straightforward than for market sectors.  
 
There are two ways to overcome the problem and construct an equivalent output measure for non-
market. The first way is to substitute information about the price of the output with its cost of 
production, making the assumption that marginal costs equate to marginal social values. If so, the 
output measure in Laspeyres form becomes: 
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  ? ௦ܻ ?௅ேெ௞௧ ൌ  ? ௫ೕ೟௖ೕ೟షభೕ ? ௫ೕ೟షభ௖ೕ೟షభೕ  (1.4) 
 
However, if marginal costs diverge from marginal social values, this index reflects producer rather 
than consumer valuations of output [2]. 
 
The second way requires a means of assessing the value of non-traded products. A common means 
of doing this is by describing the characteristics ሺ݃ሻ of each product, recognising that products with 
more desirable characteristics are of greater value. The approach requires quantification of the 
various characteristics ሺݍ௚ሻ of each product and assessing the marginal social value ሺߨ௚ሻ of each 
characteristic. This makes it possible to construct an alternative output measure, whereby prices are 
ƌĞƉůĂĐĞĚďǇĂŵĞĂƐƵƌĞĐĂƉƚƵƌŝŶŐƚŚĞƌĞůĂƚŝǀĞǀĂůƵĞŽĨĞĂĐŚƉƌŽĚƵĐƚ ?ƐĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ[3], such that: 
  ? ௦ܻ ?௅ேெ௞௧ ൌ  ? ௫ೕ೟ೕ  ? ௤೒ೕ೟గ೒೟షభ೒ ? ௫ೕ೟షభೕ  ? ௤೒ೕ೟షభగ೒೟షభ೒         (1.5) 
 
In common parlance, this bundlĞŽĨĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐƌĞĨůĞĐƚƐƚŚĞŽǀĞƌĂůů ‘ƋƵĂůŝƚǇ ?ŽĨƚŚĞƉƌŽĚƵĐƚ ?
Hence, construction of this measure requires assessment of the quality characteristics of each 
product. 
 
A combination of these two general approaches has been adopted to assess the contribution of the 
English National Health Service (NHS) in the national accounts. In section 2 we describe the current 
approach used to capture changes in the costs and characteristics of healthcare outputs and the 
data used to measure these characteristics.  
 
There are concerns, though, that other important characteristics are not captured adequately and 
that NHS output should account for additional indicators of the quality of healthcare [4]. In section 3 
we consider criteria for selecting potentially appropriate characteristics of healthcare outputs. We 
first describe existing sets of criteria, focusing on those developed by national bodies responsible for 
assessing healthcare system performance. We also held a workshop to gather the opinions of UK 
experts on quality and productivity measurement.  
 
In section 4 we set out seven criteria that indicators of the quality of health care services ought to 
satisfy in order to be considered as candidates for inclusion in a measure of NHS output growth.  
 
In section 5, we assess the indicators published as part of the NHS Outcomes Framework and the 
NHS Thermometer data against the criteria set out in section 4. For this process we identify those 
indicators that offer the greatest potential to be included in the NHS output measure. We conclude 
in section 6. 
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2. Accounting for the quality of healthcare output 
There is a great deal of variation among health service users in terms of the nature of their contact 
with the health system and what this contact seeks to achieve. To capture output, it is necessary to 
define and measure  ‘completed treatments ? ?and this implies a time-limited unit of measurement.  
However, this is challenging particularly for patients with chronic conditions whose contact with the 
heath system is ongoing. Standard practice, therefore, has been to count the number of discrete 
activities (actions) undertaken by the various organisations that comprise the health sector [5].  
 
Quality adjustment of these activities is difficult mainly because people do not demand healthcare 
for its own sake, but because of the contribution it makes to their health status. This requires some 
means of measuring the health outcome associated with treatment. People also value the process 
by which healthcare is delivered, such as whether they are treated with dignity and respect, and how 
quickly they can access services. Therefore, a measure of health care output should seek to capture 
aspects of both process and outcome of healthcare activities.  
 
An obvious way of capturing the impacts of NHS treatment on health outcomes is to measure 
Quality Adjusted Life Years (QALYs). Therefore, this section first sets out how QALYs could be used in 
an ideal world, and considers the operational challenges of implementation in the real world 
(subsection 2.1).  Given the absence of routinely available data on QALYs, the next subsection 
describes how quality adjustment is currently implemented using available data (2.2).  Finally, we 
discuss a potential source of QALY data and consider its relevance and applicability for an alternative 
approach to the capturing the quality of NHS output.   
 
2.1 Measuring health outcomes: the QALY approach 
Ideally, measures of health outcome should indicate the value added to health as a result of contact 
with the health system. In the UK, a common metric to describe health outcome is the QALY, which 
captures information about both the length and quality of life. This can be used to assess the 
contribution of treatment to health outcomes, and is the metric recommended by the National 
Institute for Health and Care Excellence (NICE) in health technology assessment [6].  
 
To see how QALYs are measured, consider a patient requiring an urgent heart operation (Figure 1), 
with life expectancy on the x axis and health-related quality of life on the y axis, with values ranging 
from 0=death to 1=perfect quality of life. Left untreated, she is expected to live for just one year 
with a poor quality of life (QoL = 0.4). However, if the patient receives treatment, she is expected to 
live for 5 years with a higher quality of life for each of these years (QoL = 0.6). Without treatment, 
the number of QALYs the patient is expected to have equals to 1*0.4 = 0.4 QALYs. If the operation 
takes place, the number of QALYs increases to 5*0.6 = 3 QALYs. The QALY gain the patients enjoys 
when receiving the treatment is, therefore, 3-0.4=2.6 QALYs.  
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Figure 1: QALY gain 
 
The QALY gain is the health produced by the healthcare system or NHS. If we could observe the 
health gains from all patients treated by the NHS over time, we could use this information to 
measure the performance of the NHS health system, using the total amount of QALYs to capture the 
total amount of health output produced by the health system. 
 
So, if the without and with treatment number of QALYs is known for all patients receiving treatment 
of type j we can construct an output growth measure   ? ொܻ஺௅௒ that measures the growth in total 
QALYs between years t-1 and t aggregated across each activity j for the whole healthcare system: 
  ? ொܻ஺௅௒ ൌ   ? ௩೔೟ಿ೟೔సభ ? ௩೔೟షభಿ೟షభ೔సభ           (2.1) 
 
where ݒ௜௧ is the difference in QALYs without and with treatment (ie the number of QALYs gained) for 
patient i in year t and ௧ܰ is the total number of patients treated in year t. 
 
There are three key challenges with operationalising this approach. First, there is the problem of 
attribution. Some improvements in health status may be due not to the activities of the health 
system, but reflect the influence of other types of care (e.g. social care) or of wider social 
determinants of health [7]. The challenge is to isolate the specific contribution of health services to 
health outcome. 
 
Second, the without treatment counterfactual  W what health status would have been in the absence 
of intervention  W is rarely observed. Instead, health status measurement tends to rely on 
comparisons of health states before and sometime after intervention. For the purposes of 
measuring output growth in the national accounts, before and after measures can supply sufficient 
information on which to make temporal comparisons [7]. This would be the case if the 
counterfactual without-treatment profile can be assumed not to change from one year to the next. If 
so, before-and-after measures can be used to assess whether the with-treatment health profile 
changes over time, thus providing enough information with which to judge whether health 
outcomes have improved.  
 
Third, data are not routinely collected about the health consequences of ƉĂƚŝĞŶƚƐ ?contact with the 
health system. This makes it difficult to assess the impact of treatment on their quality of life. This 
lack of information is the reason why current practice in England has been to try to piece together 
measures of QALYs indirectly from other information. We describe this practice next. 
Quality of Life 
Life expectancy 
[in years] 
0.6 
0.4 
 
 
QALY gain 
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2.2 The current approach to quality adjustment 
In the absence of comprehensive and routinely collected data on QALYs, the current quality 
adjustment of NHS output makes use of routinely available information in order to capture the 
quality of life and extensions to length of life associated with treatments [3]. For patients treated in 
hospital, the adjustment takes the form: 
 
 ?ݍ௝௛௢௦௣ ൌ ൬ ௔ೕ೟ି௞ೕ௔ೕ೟షభି௞ೕ൰ ቎൬భష೐
షೝಽಽೕ೟ ൰ೝಽ ିቀ೐ೝೢೢೕ೟షభቁೝೢ ቏
቎൬భష೐షೝಽಽೕ೟షభ൰ೝಽ ିቀ೐ೝೢೢೕ೟షభషభቁೝೢ ቏       (2.2) 
 
Given that direct QALY estimates for each type of hospital activity (defined using Healthcare 
Resource Groups (HRGs)) are unavailable, an equivalent of a QALY profile for patients allocated to 
each healthcare output is constructed [8]. A survival measure ሺܽ௝ሻ captures the probability of 
survival following hospital treatment for people in each relevant HRG. We multiply this probability 
by life expectancy ሺܮܧ௝ሻ and a measure of change in health status following treatment ሺ ௝݇ሻ to arrive 
at an estimate of the total amount of QALYs experienced by this group of survivors over their 
remaining lifetime. Those who do not survive hospital treatment are afforded a zero QALY gain.  
 
There is also recognition that the process of care delivery matters. Waiting for treatment ሺݓ௝ሻ yields 
disutility, and this disutility is expressed in terms of QALYs by valuing days spent waiting in the same 
metric as the valuation of remaining life expectancy. This allows one to subtract the disutility 
associated with waiting from the QALY gains associated with treatment in order to arrive at an 
estimate of net QALY gains for each HRG. 
 
Survival ሺܽ௝ሻ is measured as the 30-day post admission survival rates for each output in each 
hospital. The change in health status ሺ ௝݇ሻ is measured as the ratio of average health status ሺ݄଴ሻ 
before and after ሺ݄כሻ treatment, such that  ௝݇ ൌ ௝݄଴ ௝݄כ൘  . In the absence of HRG-specific information, 
this ratio is assumed to be 0.8 for electives and 0.4 for non-electives and both remain constant over 
time [3].  
 
For a handful of conditions, HRG-specific information about before and after treatment health status 
data is available via the Patient Reported Outcome Measure (PROM), which is a patient level survey 
asking about health status [9]. This survey is currently administered only to patients having hip 
replacement, knee replacement, hernia repair and varicose vein removal, representing less than 2% 
of all hospital patients. For patients having these treatments the change in health status, ௝݇ , is taken 
from their pre- and post-treatment survey responses. 
 
Life expectancy ሺܮܧ௝ሻ associated with each HRG is calculated by considering the age and gender 
profiles (in 5-year bands) of patients allocated to each HRG, based on life tables published by the 
Office of National Statistics (ONS) [10]. The inverse exponential function reflects decreasing life 
expectancy over time and ݎொ is the discount rate applied to future life years. 
 
Waiting times ሺݓ௝ሻ for each HRG in each hospital are measured at the 80th percentile of the 
distribution for patients categorised to each HRG. This formulation implies that delays to treatment 
have adverse health consequences and that the marginal disutility of waiting increases as the delay 
increases, with the disutility captured as an exponential function and by the discount rate ݎ௪ [3].   
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The way that each type of hospital output is weighted to take account of its quality can be seen as a 
function of three ratios: 
 
A survival and health effect ratio ቆ ௝ܽ௧ െ ௝݇௝ܽ௧ିଵ െ ௝݇ቇ 
A life expectancy ratio ቆ ൫ ? െ ݁ି ௥ಽ௅ೕ೟ ൯൫ ? െ ݁ି ௥ಽ௅ೕ೟షభ൯ቇ 
A waiting time ratio  ቆ ݁ି௥ೢ ௪ೕ೟ െ  ?݁ି௥ೢ ௪ೕ೟షభ െ  ?ቇ 
 
Not all ratios are applied to each type of hospital activity. For example, patients treated as 
emergencies (non-elective patients) do not wait for treatment, so the waiting time ratio is assumed 
to be equal to 1. For outpatient activity, no survival and life expectancy data are available, and thus 
only the waiting time ratio is applied.  
 
There is a different way of accounting for the quality of primary care [11]. The approach utilises data 
captured as part of the Quality and Outcomes Framework (QOF), under which GPs are rewarded for 
achieving a range of diverse targets. If disease management in primary care is improving over time, 
the supposition is that this will be reflected in reduced blood pressure for an increasing proportion 
of patients with coronary artery disease (CHD), stroke and hypertension. Hence, primary care 
consultations are deemed to be 30% more valuable if a blood pressure reading equal or below the 
target of 150/90 is recorded. 
 
To incorporate these aspects of quality into an output index for primary care, information is required 
about the prevalence rate for each of these three conditions, the QOF success rate, and the value of 
a consultation where a successful (below target) blood pressure reading is taken relative to other 
consultations. So, the volume of primary care consultations ሺݔ௝ሻ is weighted upwards if any feature 
successful blood pressure management, with the measure of primary care output being formulated 
as: 
  ? ௝ܻ௧௣௖ ൌ ௫ೕ೟ൣ଴Ǥଷכ ? ௉೘೟ௌ೘೟య೘సభ ൧௫ೕ೟షభൣ଴Ǥଷכ ? ௉೘೟షభௌ೘೟షభయ೘సభ ൧        (2.3) 
 
Where ݉ indexes the three conditions  ݉ ൌ  ? ǥ  ?,  ௠ܲ is the prevalence rate for condition ݉ and ܵ௠  is the QOF success rate for condition ݉. 
 
Table 1 provides an overview of the current information used to account for the quality of NHS 
output, and shows which settings are covered. 
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Table 1: Quality adjustments for cost-weighted output 
Setting NON-ELECTIVE ELECTIVE / DAY CASE 
INPATIENT  
 
30-day survival (by HRGs) 
Remaining life expectancy (by 
HRGs) 
30-day survival (by HRGs) 
Remaining life expectancy (by 
HRGs) 
80th percentile of waiting times 
(by HRGs) 
OUTPATIENT 
 
 80th percentile of waiting times1 
PRIMARY CARE  QOF Blood Pressure indicators:  
Chronic Heart Disease 
Stroke 
Hypertension 
Key: HRG: Healthcare Resource Groups; QOF: quality and outcomes framework. 
Sources: [12, 13] 
 
2.3 An alternative source of QALYs 
Whilst there are no routine national datasets of QALYs for NHS patients, there is an alternative 
source that should be considered for its potential relevance, namely data from a project that sought 
to develop methods for estimating the NICE cost-effectiveness threshold [14]. The project aimed to 
estimate the relationship between changes in overall NHS expenditure and changes in mortality and 
to translate these estimates into broader effects in terms of QALYs. To support this aim, one of the 
objectives of the ǁŽƌŬǁĂƐƚŽĞƐƚŝŵĂƚĞ “ƚŚĞƋƵĂůŝƚǇŽĨůŝĨĞ ?YŽ> ?ĂƐƐŽĐŝĂƚĞĚǁŝƚŚĂĚĚŝƚŝŽŶĂůǇĞĂƌƐŽĨ
ůŝĨĞĂŶĚƚŚĞĚŝƌĞĐƚŝŵƉĂĐƚŽĨŚĞĂůƚŚƐĞƌǀŝĐĞƐŽŶYŽ> ?In theory, estimates from this project could 
replace some of the arguments in equation 2.2 above. 
 
There were two key elements to the QALY estimates constructed as part of the project. The first 
element consists of estimated effects of changes in NHS expenditure on mortality, described in 
terms of years of life gained (YLG). These gains reflect how changes in health expenditure impact on 
ŵŽƌƚĂůŝƚǇĂŶĚƚĂŬĞ “ŝŶƚŽĂĐĐŽƵŶƚƚŚĞ ‘ĐŽƵŶƚĞƌĨĂĐƚƵĂů ?ĚĞĂƚŚƐƚŚĂƚǁŽƵůĚŚĂǀĞŽĐĐƵƌƌĞĚŝĨƚŚĞ
population [in a particular expenditure category]  QĨĂĐĞĚƚŚĞƐĂŵĞŵŽƌƚĂlity risks as the general 
population ? [14]. The second element adjusts the YLG estimates to reflect how QoL differs by age 
and gender. There are two forms of QoL adjustment, differing according to the source of the data. 
 
The first form, ௗܻ௚ொଵ, uses data from the Health Outcome Data Repository (HODaR) [15] which 
 “ƉƌŽǀŝĚĞƐŽǀĞƌ ? ? ? ? ? ?ŽďƐĞƌǀĂƚŝŽŶƐŽĨY-5D2 measures of quality of life by ICD103 code and the age 
ĂŶĚŐĞŶĚĞƌŽĨƚŚĞƉĂƚŝĞŶƚƐŝŶƚŚĞƐĂŵƉůĞ ? supplemented with information from the Medical 
Expenditure Panel Survey (MEPS) ?&ŽƌƚŚĞƉƌŽũĞĐƚ ? “ƚŚĞƐĞĚĂƚĂƉƌŽǀŝĚĞĚĂŵĞĂŶƐŽĨĞƐƚŝŵĂƚŝŶŐƚŚĞ
quality of life associated with each ICD code at the average age of respondents in the pooled 
ƐĂŵƉůĞ ? [14]. The data are available online.4 
 
This form of the adjustment can be written: 
 ௗܻ௚ொଵ ൌ ܻܮܩௗ௚݄ௗଵ          (2.4) 
 
                                                        
1 See Dawson 2005, CHE RP6, p96 (section 4.10.5; Table 4.7) 
2 EuroQol five dimensions questionnaire https://euroqol.org/ 
3 International Statistical Classification of Diseases and Related Health Problems 10th Revision 
4 https://www.york.ac.uk/media/che/documents/Appendix%20A%20(Displacement%20by%20ICD%20code).xlsx 
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Where ௗܻ௚ொଵ indicates the first form of the QALY adjustment, d denotes diagnostic (ICD10) groups and 
g 5-year age and gender groups. ܻܮܩௗ௚ indicates the years of life gained, by diagnostic and 
age/gender band. In this formulation, the estimates of YLG are weighted according to the quality of 
life ݄ௗଵ  HODaR/MEPS survey responses by diagnostic group (but not by age and gender, because the 
pooled sample was too small).  
 
The second form, ௗܻ௚ொଶ, ĂƉƉůŝĞƐ “YŽ> ‘ŶŽƌŵƐ ?ĨŽƌƚŚĞŐĞŶĞƌĂůƉŽƉƵůĂƚŝŽŶďǇĂŐĞĂŶĚŐĞŶĚĞƌďĂƐĞĚŽŶ
an analysis of data from the Health Survey ĨŽƌŶŐůĂŶĚ ?,^ ? ? ?dŚĞƌĞƐƵůƚŝŶŐY>zĨŽƌŵƵůĂƚŝŽŶĐĂŶďĞ
written as: 
 ௗܻ௚ொଶ ൌ ܻܮܩௗ௚݄௚ଶ         (2.5) 
 
The estimates of YLG are weighted using the HSE health-related quality of life ݄௚ଶ norms for the 
general population by age and gender (but not by diagnosis).  
 
It may be that the data used to construct these two calculations of QALYs could be used in the 
quality adjustment measure for calculation productivity growth. We consider the estimation of 
mortality effects and of quality of life effects in turn. 
 
Mortality effects 
We could substitute the ܻܮܩௗ௚ estimates for the life expectancy estimates  ܮ௝  (which also take 
account of the age/gender composition so, comparably, can be written ܮ௚௝).  
 
There are two potential advantages to using ܻܮܩௗ௚ estimates. First, as ܻܮܩௗ௚ estimates are 
available by ICD10 codes, these estimates could be applied to match the diagnostic composition of 
patients within each HRG, to arrive at estimates of ܻܮܩ௝. This would allow changes in the diagnostic 
composition of patients in each HRG to be captured, rather than changes in just the age 
composition, as currently.  
 
Second, the ܻܮܩௗ௚ ĞƐƚŝŵĂƚĞƐĂƚƚĞŵƉƚƚŽĐĂƉƚƵƌĞƚŚĞ “ĞĨĨĞĐƚƐŽŶŵŽƌƚĂůŝƚǇƚŽůŝĨĞǇĞĂƌƐƚĂŬŝŶŐŝŶƚŽ
ĂĐĐŽƵŶƚƚŚĞ ‘ĐŽƵŶƚĞƌĨĂĐƚƵĂů ?ĚĞĂƚŚƐƚŚĂƚǁŽƵůĚŚĂǀĞŽĐĐƵƌƌĞĚŝĨƚŚĞƉŽƉƵůĂƚŝŽŶ QĨĂĐĞĚƚŚĞƐĂŵĞ
ŵŽƌƚĂůŝƚǇƌŝƐŬƐĂƐƚŚĞŐĞŶĞƌĂůƉŽƉƵůĂƚŝŽŶ ? ?dŚĞĂĚǀĂŶƚĂŐĞŝƐ ĐƌŝƚŝĐĂůǁŚĞŶŵĂŬŝŶŐĐŽŵƉĂƌŝƐŽŶƐĂĐƌŽƐƐ
disease areas, because comparisons must be based on the QALYs gained as a consequence of 
treatment, relative to what would have been experienced in the absence of treatment.  
 
Calculation of QALY gains is less critical, though, when measuring changes over time in mortality or 
life expectancy, as required in measuring output growth, when it is necessary only to assess changes 
in the with-treatment health profile over time, under the assumption that the counterfactual  W what 
happens in the absence of treatment  W is constant over time for each patient group  [3, 7].  
 
The disadvantage of using ܻܮܩௗ௚ is that these data are not strictly comparable to our life expectancy 
estimates ܮ௝ . The mortality effects ܻܮܩௗ௚ are estimates of the impact on mortality of a £1 change in 
NHS expenditure, built up from estimates of (i) the deaths averted per pound spent and translated 
into (ii) life years gained according to the age at which a disease-specific death typically occurs. The 
first component is not required for the measurement of output growth. The second element is based 
on the ONS life tables [10], just as for ܮ௝  in equation 2.2, the difference being that the former are 
applied by disease-group rather than HRG. Thus, with respect to the life expectancy effects, the NICE 
cost-effectiveness threshold project and the life expectancy formulation in equation 2.2 adopt a 
broadly equivalent approach and the same data. 
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Quality of life effects 
We could substitute either ݄ௗଵ  or ݄௚ଶ for ௝݇  in equation 2.2. Note that none of these arguments 
include a time dimension, with values not varying over time. This means that the choice of which 
argument to use boils down to a preference about the quality of the QoL measures.  
 
In our current practice, for only a handful of HRGs are actual QoL data available, these being the four 
conditions for which Patient Reported Outcome Measures are collected. For all other patients 
treated in hospital, we assume that the ratio of average health status before and after treatment, 
amounts to 0.8 for elective patients and 0.4 for non-elective patients and that these ratios remain 
constant over time. On the face of it, relaxing these assumptions using either ݄ௗଵ  or ݄௚ଶ would seem 
advantageous. But this depends on the quality of the underlying data.  
 
The Health Outcome Data Repository (HODaR) provides over 30,000 observations of EQ-5D 
measures of quality of life by ICD code ?dŚĞĚĂƚĂǁĞƌĞĚĞƌŝǀĞĚĨƌŽŵƉĂƚŝĞŶƚƐ “ƚƌĞĂƚĞĚĂƚĂƌĚŝĨĨĂŶĚ
Vale NHS hospital from 2002 to 2004. Inpatients were surveyed 6 weeks post-discharge whilst 
outpatients are handed a survey package when they atƚĞŶĚ ? ?ƌĞĨƉ ? ? ?ƚŚƌĞƐŚŽůĚƉƌŽũĞĐƚƌĞƉŽƌƚ ? ? 
 
On the face of it these data could substituted for ௝݇  by applying the ݄ௗଵ  estimates to each patient 
according to their primary diagnosis, and aggregating these to HRGs to derive estimates at HRG 
level, ݄ௗ௝ଵ . In our original work [3] we considered this possibility, and examined the quality of the 
HODaR data. We found that the data do not constitute before and after measures of health status, 
with multiple observations only available for a fairly small proportion of patients. Moreover, for 
those with multiple observations, the time intervals varied considerably and the ICD10 codes often 
changed from one survey to the next, suggesting that they are receiving treatment for different 
underlying conditions. We concluded that the data were not fit for purpose because it was not clear 
what the HODaR data were actually capturing: 
 
We have analysed the HODaR set of observational data to ascertain whether the information can be 
utilised in the construction of outcome weights for a productivity index. We have concluded that the 
HODaR data are unsuitable for this purpose. The surveys have not been administered with the 
express intention of collecting before and after information. Although multiple surveys exist for a 
subset of patients, it is unlikely that many of these constitute before-and-after measurements. (Page 
64, Technical appendices to [3]) 
 
For the NICE cost-effectiveness threshold project, the HoDAR/MEPS data were interpreted as 
providing a measure of QoL associated with the disease under current care arrangements but not as 
providing a measure of the changes in QoL as a consequence of treatment. The use of ݄ௗଵ  in the NHS 
output measure, therefore, does not seem worth pursuing. 
 
Estimates of ݄௚ଶ are derived from the Health Survey for England (HSE), which is designed to be 
representative of the English population. These estimates were derived after pooling data from six 
surveys (1996, 2003-2006 and 2008).  
 
The estimates could be applied to reflect changes in the age/gender composition of patients in each 
HRG each year, to arrive at an estimate of ݄௚௝ଶ . This would involve substituting ௝݇   for ݄௚௝ଶ  in equation 
2.2. This would be an improvement on our current practice of using estimates for all elective and all 
non-elective patients. But the underlying QoL estimates would remain time-invariant, deriving from 
the pooled HSE surveys. For it to be worth moving to this form of quality adjustment, at the very 
least the estimates of ݄௚ଶ would need to be updated, given that the most recent survey data on 
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which they are based date from 2008. Moreover, as with HoDAR/MEPS data, the estimates of ݄௚ଶ do 
not provide a measure of the changes in QoL as a consequence of treatment. 
 
In summary, therefore, the data used for the NICE cost-effectiveness threshold project offer 
insufficient improvement to our current quality adjustment approach. A better avenue might be to 
seek to supplement our quality adjustment with indicators that measure different elements of 
quality not captured directly as QALYs. We explore this in the remainder of the report. 
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3. Review of existing criteria for indicator selection 
In the absence of off-the-shelf and regularly updated measures of the change in QALYs associated 
with NHS treatment, and having ruled out the NICE cost-effectiveness threshold project as a viable 
alternative, we then considered whether and how other routine indicators of the quality of care 
could be incorporated into the measure of NHS output growth. This involved establishing a set of 
criteria that potential indicators ought to satisfy if they are to be considered for inclusion. We set 
about establishing these criteria in two stages. 
 
First, we searched for criteria that had been developed by national bodies responsible for collating 
and publishing measures of patient safety and quality. These criteria are not about the type of 
quality (i.e. the content of the indicators) but rather relate to the properties of indicators that make 
them suitable for measuring quality. We undertook a detailed review of three of these criteria sets: 
 
x AHRQ 2008 (Agency for Healthcare Research and Quality (US)) 
x NCHOD 2005 (National Centre for Health Outcomes Development) 
x HSCIC 2014 (Health and Social Care Information Centre) 
 
Second we presented our findings from this review at a workshop attended by UK experts in 
healthcare quality and/or in the measurement of healthcare output and productivity indices.  We 
asked participants to suggest the criteria that indicators should satisfy if they are to be included in an 
NHS output index.   
 
3.1 AHRQ criteria used to evaluate potential quality indicators 
The Agency for Healthcare Research and Quality (AHRQ) is a US government agency responsible for 
ŝŵƉƌŽǀŝŶŐƚŚĞƐĂĨĞƚǇĂŶĚƋƵĂůŝƚǇŽĨŵĞƌŝĐĂ ?ƐŚĞĂůƚŚĐĂƌĞ ?/ƚŚĂƐĚĞǀĞůŽƉĞĚĂƌĂŶŐĞŽĨĞǀŝĚĞŶĐĞ-
based quality indicators to assess performance, and to identify variations in care quality. AHRQ 
quality indicators are updated annually and are frequently used in research projects as well as for 
comparative reporting and performance assessment within the US healthcare system [16]. In 1998, 
researchers at University of California, San Francisco (UCSF) and the Stanford University Evidence-
ĂƐĞĚWƌĂĐƚŝĐĞĞŶƚĞƌ ?W ?ǁĞƌĞĐŽŵŵŝƐƐŝŽŶĞĚƚŽƌĞǀŝĞǁĂŶĚƌĞǀŝƐĞƚŚĞ,ZY ?ƐĞǆŝƐƚŝŶŐƐĞƚŽĨ
indicators [17]. Based on a literature review, and informed by interviews with a wide range of 
stakeholders (including academics), the researchers produced a set of criteria, see (Table 2) for 
evaluating potentially viable indicators [16].   
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Table 2: AHRQ criteria 
Face validity  An adequate quality indicator must have sound clinical or empirical rationale for its 
use. It should measure an important aspect of quality that is subject to provider or 
healthcare system control.  
Precision  An adequate quality indicator should have relatively large variation among providers or 
areas that is not due to random variation or patient characteristics. This criterion 
measures the impact of chance on apparent provider or community health system 
performance.  
Minimum bias  The indicator should not be affected by systematic differences in patient case mix, 
including disease severity and comorbidity. In cases where such systematic differences 
exist, an adequate risk-adjustment system should be possible using available data.  
Construct validity  The indicator should be related to other indicators or measures intended to measure 
the same or related aspects of quality. For example, improved performance on 
measures of inpatient care (such as adherence to specific evidence-based treatment 
guidelines) ought to be associated with reduced patient complication rates.  
Fosters real 
quality 
improvement  
The indicator should be robust to possible provider manipulation of the system. In 
other words, the indicator should be insulated from perverse incentives for providers 
to improve their reported performance by avoiding difficult or complex cases, or by 
other responses that do not improve quality of care.  
Application  The indicator should have been used in the past or have high potential for working well 
with other indicators. Sometimes looking at groups of indicators together is likely to 
provide a more complete picture of quality.   
Source: AHRQ. Refinement of the HCUP Quality Indicators, p. 30. 
 
3.2 NCHOD Criteria (matrix) for evaluating the quality of indicators  
In 2005, the National Centre for Health Outcomes Development (NCHOD) published a new set of 
ĐƌŝƚĞƌŝĂ ? ‘ŵĂƚƌŝǆ ? ?ĨŽƌĞǀĂůƵĂƚŝŶŐƚŚĞƋƵĂůŝƚǇŽĨĐůŝŶŝĐĂůĂŶĚŚĞĂůƚŚŝŶĚŝĐĂƚŽƌƐ [18]. Reviewing 18 
independent sources on criteria and methods, NCHOD organised the resulting indicators into four 
groups: scientific criteria; policy criteria; methodological criteria; and statistical criteria. A summary 
of these criteria is presented in Table 3. 
 
dŚĞƐĞĨŽƵƌƐĞƚƐŽĨĐƌŝƚĞƌŝĂĂƌĞĨƵƌƚŚĞƌƐƵďĚŝǀŝĚĞĚŝŶƚŽƚŚƌĞĞƉŚĂƐĞƐŽĨƚŚĞŝŶĚŝĐĂƚŽƌ ?ƐůŝĨĞĐǇĐůĞ P
 
x Development (scientific criteria; policy criteria)  
x Measurement (methodological criteria)  
x Interpretation (statistical criteria) 
 
dŚĞƐĞƉŚĂƐĞƐĂƌĞƉƌŽŐƌĞƐƐŝǀĞ ?ŝ ?Ğ ?ĂŶŝŶĚŝĐĂƚŽƌŵƵƐƚƐĂƚŝ ĨǇƚŚĞ ‘ĚĞǀĞůŽƉŵĞŶƚ ?ƉŚĂƐĞďĞĨŽƌĞ
ƉƌŽŐƌĞƐƐŝŶŐƚŽĂƐƐĞƐƐŵĞŶƚĂƚƚŚĞŚŝŐŚĞƌůĞǀĞůƐ ?dŚĞ ‘ŵĞĂƐƵƌĞŵĞŶƚ ?ƉŚĂƐĞŵƵƐƚďĞƐĂƚŝƐĨŝĞĚďĞĨŽƌĞ
ĐƌŝƚĞƌŝĂŝŶƚŚĞ ‘ŝŶƚĞƌƉƌĞƚĂƚŝŽŶ ?ƉŚĂƐĞĂƌĞĂƉƉůŝĞĚ ?/ŶĚŝĐĂƚŽƌƐĂƌĞƚŚĞŶĂƐƐĞƐƐĞĚĂŐĂŝŶƐƚĞĂĐŚƋƵĂůŝƚǇ
criteria using a 5-star rating system (* =v. poor; ***** =v. good). 
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Table 3: NCHOD Criteria 
Scientific criteria (SC) Code 
Explicit definition Is the indicator explicitly defined by appropriate statistical units of 
measurement and clinical terminology? 
SC1 
Indicator validity Will the indicator measure the phenomenon it purports to measure i.e. does 
it makes sense both logically and clinically? 
SC2 
Scientific soundness How scientific is the evidence / selection process (systematic / non-
systematic) to support the validity of the indicator? 
SC3 
Policy criteria   
Policy-relevance Does the phenomenon under measurement represent significant public 
interest, disease burden or cost? 
P1 
Actionability Can the factors which influence the phenomenon be positively influenced to 
induce a future health / cost benefit? 
P2 
Perverse incentives Will the measurement process encourage undesired behaviours by those 
under measurement? 
P3 
Methodological criteria (M)  
Explicit 
methodology 
Are measurement tools / procedures explicitly defined, understood and 
monitored? 
M1 
Attributability Are the factors which influence (+/-ve) the phenomenon likely to be 
identified e.g. patient risk factors, practitioner procedure etc? 
M2 
Timeliness What is the average time (months) between measurement and results? M3 
Frequency What is the average time (months) between reporting of results? M4 
Sensitivity to 
change 
Do the measurement tools and timing of results allow changes to be 
observed over time? 
M5 
Confounding What is the risk that variations between organisations and changes over time 
may be influenced by confounding factors? 
M6 
Acceptability What % stakeholders accept the process of measurement and the reasons 
for it? 
M7 
Measurability Is the measurement process possible within the available budget and 
resources? 
M8 
Cost-effectiveness Does the likely output represent a cost-effective use of budget/resources? M9 
Statistical criteria (SP)  
Specificity Does the measurement appropriately capture the level of detail required e.g. 
sub-group analyses, accurate diagnosis? 
SP1 
Comparability Is the measure comparable between relevant sub-groups e.g. are 
age/sex/geography-specific data standardised and consistent? 
SP2 
Representativeness Are sample sizes representative across all required sub-groups SP3 
Data quality % of the information missing from the records? SP4 
Data reliability % agreement (kappa coefficient) between measured records and those 
collected by an independent source?  
SP5 
Uncertainty Have appropriate techniques been selected to demonstrate the effects of 
variation, dispersion and uncertainty (Shewhert, funnel plots etc.)? 
SP6 
Interpretability Can understandable, meaningful and communicable conclusions be drawn 
from the results? 
SP7 
^ŽƵƌĐĞ PE,K ?ƐŵĂƚƌŝǆ ?ƚŚĞĐŽĚĞƐĂƌĞŽƵƌŽǁŶĂďďƌĞǀŝĂƚŝŽŶƐ ? ? 
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3.3 HSCIC (Indicator Assurance Service) 
The Health and Social Care Information Centre5 (HSCIC) is the national provider of information, data 
and IT systems for health and social care In England. HSCIC has an assurance process for determining 
the suitability of quality indicators for use in the National Library of Quality Assured Indicators.6 The 
HSCIC criteria are [19] 7 
 
x Clarity: Is it clear what the indicator will measure? 
x Rationale: What are the reasons and evidence for measuring this? 
x Data: Is the data in the measure fit (enough) to support the purpose? 
x Construction: Will the methods used support the stated purpose? Is it clear what methods 
are used and how they have been tested and justified? 
x Interpretation: Is the presentation of the indicator suitable and are all potential users able 
to interpret the values? Can the indicator be used for quality improvements? 
x Risks: Are any limitations, risks or perverse incentives associated with the indicator explicitly 
stated?  
 
Each of these headline criteria is accompanied by further explanatory statements. These are 
reproduced in Table 4. 
 
Table 4: HSCIC List of Criteria (2014) 
1. Clarity: Is it clear what the indicator will measure?  
a)  A unique name for the measure which is sufficiently descriptive to convey meaning when referenced or quoted without 
supporting meta-data and differentiates it from, or specifically associates it with, other indicators.  
b)  A clear and unambiguous description of the measure, which is expressed both in plain English and the relevant clinical 
and/or statistical terminology of the particular subject in question, and which is suitable for a diverse audience.  
c)  A clear statement about the measurement units, and reasons why that unit has been chosen as relevant.  
d)  A clear statement about the scope of the indicator, which will typically include aspects such as detailed patient, 
population, disease group, geographical and geographical granularity coverage.  
e)  All other major inclusions and exclusions should be stated in the indicator definition.  
2. Rationale: Are the reasons and evidence for measuring this clear?  
a)  The sponsor for the measure should be clearly stated.  
b)  A clear statement about the purpose of the measure.  
c)  A clear identified gap or need for the indicator.  
d)  Justification as to why this is a sufficiently important question/service that requires measurement.  
e)  A clear statement about the evidence base for the measure such as clinical evidence or professional consensus, and if 
relevant it should be acceptable to those whose behaviour and practices this may be applied.  
f)  A clear statement of the policy objective and/or critical business question that the measure is seeking to capture. The 
rationale must be clearly set out, be plausible, and capable of being understood by a diverse audience including the 
public.  
g)  If the indicator fits into a framework, the rationale for the framework as a whole and an outline of how the indicator is 
included.  
h)  Previous decision-making documents are included for reference.  
3. Data: Is the data in the measure fit to support the purpose?  
a)  The source of the data is clearly identified with justification, including the extent of any intermediate processing steps 
which might predispose the data to errors or bias. How data will be extracted or collected is included, with justification 
if required.  
                                                        
5 The Health and Social Care Information Centre changed name to NHS Digital in April 2016. 
6  http://content.digital.nhs.uk/article/5173/Appraisal-end-to-end-process 
7  http://content.digital.nhs.uk/article/5171/Quality-Criteria 
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b)  Whether the indicator data source is re-using a collection/extraction or is primarily being collected / extracted for the 
indicator is discussed.  
c)  Alternative data sources have been considered with justification as to why they were not used.  
d)  Data availability is discussed, including the form in which it is available, who has access to the data and evidence that it 
is available with sufficient frequency and timeliness to enable desired improvement actions to be visible. The 
availability of data long-term has been considered.  
e)  The data used is robust enough to support the measure and its derivations. The quality of the data is above the 
threshold of acceptability, and this threshold is explicitly defined in the method, and accepted by all stakeholders. The 
effect of data quality issues upon the measure are explicitly known and declared.  
f)  An explicit definition of any exclusions from the scope, (which might include specific instances, or be based on 
calculated or derived rules) along with justification as to why these have been excluded.  
4. Construction: Will the methods used support the stated purpose? Is it clear what methods are used and how they have 
been tested and justified?  
a)  The measure construction, and/or relevant derivations from it are explicitly defined and justified, to the extent that it is 
possible to reconstruct the measure and/or derivations using the same base data.  
b)  The construction of the indicator is fit for purpose and supports the stated rationale.  
c)  The element of chance has been appropriately considered in the design of the measure, and in any associated 
derivations or statistical models.  
d)  Indicator is sensitive to changes in true events.  
e)  An assessment has been made of the relevance and significance of case-mix, risk, age and sex adjustments in the 
context of the business question / improvement objective, or any other adjustments relevant to the indicator. An 
explanation as to what extent these have been carried out and any testing used to inform choice of standardisation 
method used (if relevant) should be summarised.  
f)  The use of confidence intervals or control limits has been stated, with the relevant methodology and justification.  
5. Presentation and Interpretation: Is the presentation of the indicator suitable and are all potential users able to 
interpret the values? Can the indicator be used for quality improvements? 
a)  Consideration of whether any contextual information is required to accurately interpret the indicator. Construction of 
appropriate contextual information is presented.  
b)  An explanation is provided as to whether targets or target ranges will be used with supporting evidence of how these 
are derived. Where targets are not used, how direction of travel should be interpreted by the user is provided.  
c)  The indicator is capable of detecting variability that is important enough to warrant further investigation.  
d)  Clear statement regarding how the indicator should be used and how it can be used for comparison. Clear explanation 
of when the indicator cannot be used, with justification.  
e)  A list of caveats to be presented with the indicator has been included. A thorough investigation into limitations has 
been carried out and has been addressed as successfully as possible.  
f)  Any biases resulting from scope, sample size or data collection/extraction factors have been clearly identified.  
g)  Consideration has been given to the forms of presentation of the indicator for the intended stakeholder audience. 
These are appropriate and have been tested or verified in some way.  
h)  Any common industry standard conventions for presentation have been adopted e.g. standard error bars, labelling, 
scale, limitations, exclusions etc.  
i) dŽǁŚĂƚĞǆƚĞŶƚĂĐƚŝŽŶĐĂŶďĞƚĂŬĞŶƚŽŝŵƉƌŽǀĞĂ ‘ďĂĚ ?ƉŽƐŝƚŝŽŶƐƵŐŐĞƐƚĞĚďǇĂŶĂĚǀĞƌƐĞŝŶĚŝĐĂƚŝŽŶŝƐĐlearly stated, and 
what steps can be taken to improve the measurement. Providers and commissioners are able to improve the results of 
the measurement 
6. Risks: Are any limitations, risks or perverse incentives associated with the indicator explicitly stated?  
a)  A purpose and description of any similar existing indicators are presented alongside justification as to why an additional 
indicator is needed. Differences in purpose and construct are clear and appropriate.  
b)  Methodology is consistent with other existing indicators or indicators within the same set, or justification is provided as 
to why this is not appropriate.  
c)  Consideration as to whether results of the measurement would contradict other existing indicators and any resulting 
impacts of this.  
d)  If the measure, or the process of measurement, introduces undesired behaviours by those being measured, these are 
clearly stated. If the extent of this is known or predictable, it does not invalidate utility of the indicator.  
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e)  dŽǁŚĂƚĞǆƚĞŶƚƚŚĞŝŶĚŝĐĂƚŽƌŝƐƐƵƐĐĞƉƚŝďůĞƚŽƚŚĞƌŝƐŬŽĨ ‘ŐĂŵŝŶŐ ?ŝƐĐůĞĂƌůǇƐƚĂƚĞĚ ?ŽƵƚůŝŶŝŶŐǁŚĞƚŚĞƌƚŚĞŵĞĂƐƵƌĞŝƐ
capable of being manipulated in some way to influence the outcome without the intended improvement actions taking 
place.  
f)  Issues around disclosure control have been considered. 
^ŽƵƌĐĞ P,^/ƉƵďůŝĐĂƚŝŽŶ ‘ƌŝƚĞƌŝĂĂŶĚĐŽŶƐŝĚĞƌĂƚŝŽŶƐƵƐĞĚƚŽĚĞƚĞƌŵŝŶĞĂƋƵĂůŝƚǇŝŶĚŝĐĂƚŽƌ ? ?/ŶĚŝĐĂƚŽƌƐƐƵƌĂŶĐĞ^ĞƌǀŝĐĞ ?
(2014). 
 
3.4 Expert Workshop 
In June 2016, the research team held a one day workshop with key experts in the area of health 
system productivity measurement including representatives from the Department of Health, the 
Office for National Statistics, The Health Foundation, the Nuffield Trust, Health Education England 
and the Care Quality Commission. 
 
The primary objective of the workshop was to seek expert views on the criteria that a quality 
indicator ought to satisfy in order to be incorporated in the measure of NHS output and productivity.  
Workshop participants were tasked to come up with their own list of key criteria that an indicator of 
quality should have, and to discuss these as a group exercise. Three groups were formed, each 
attended by a member of the research team. In particular, participants were posed the following 
question:  
 
 ?tŚŝĐŚZ/dZ/ƐŚŽƵůĚĂŶŝŶĚŝĐĂƚŽƌŵĞĂƐƵƌŝŶŐƚŚĞƋƵĂůŝƚǇŽĨƚŚĞŚĞĂůƚŚĐĂƌĞƐǇƐƚĞŵƐĂƚŝƐĨǇƚŽŵĂŬĞ
ŝƚƐƵŝƚĂďůĞĨŽƌƵƐĞŝŶĂŶŽƵƚƉƵƚŝŶĚĞǆ ? ? 
 
After this exercise, each group was asked to list the criteria/properties they had identified and to 
provide a short explanation as to why they were chosen and their relevance. These were related to 
all workshop participants by a spokesperson for each group and moderated by a member of the 
research team. Summaries of discussions were taken by each member of the research team 
overseeing the three group discussions. The full list of criteria proposed by workshop participants is 
reported in Box 1. 
 
Box 1 - Criteria suggested by workshop participants 
1. Clarity 
2. Not ambiguous  
3. Uni-directional 
4. Appropriately defined area of activity 
5. Value to patient / Relevant for the patient 
6. Value to clinicians 
7. Inform patient safety/improvement 
8. Coverage/comprehensiveness at national level 
9. Granularity 
10. Adjustable for different types of populations 
11. Adjustable to specific use and sector 
12. Consistency over time 
13. Timeliness 
14. Ability to capture meaningful change 
15. Specificity 
16. Sensitivity 
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The two main take-home messages of the workshop were that all criteria discussed at the workshop 
should be considered as equally important and that at least one indicator of the quality of 
healthcare delivered in each NHS settings (starting from those settings for which no quality 
dimension is currently captured) should be included in the measure of NHS output and productivity, 
provided that it is available and that it satisfies the criteria set. A warning was also provided to be 
cĂƌĞĨƵůǁŚĞŶĐŽŶƐŝĚĞƌŝŶŐ ‘ƐĂƚŝƐĨĂĐƚŝŽŶŵĞĂƐƵƌĞƐ ?ŽĨŚĞĂůƚŚĐĂƌĞƐĞƌǀŝĐĞƐĂƐƚŚĞƐĞĂƌĞƵƐƵĂůůǇ
subjective measures. 
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4. Criteria for quality indicators in output measures 
Following the workshop, we finalised our set of criteria, drawing together commonalities across the 
reviewed criteria sets and moderated by the opinion expressed by and discussions held by workshop 
participants. This generated a set of seven criteria that indicators should satisfy if they are to be 
included in a measure of output growth. 
 
After reviewing the three published criteria sets and sharing these at the workshop, we derived a set 
of criteria that measures of patient safety and quality ought to satisfy if they are to be considered for 
inclusion in a measure of NHS output. Our list of seven criteria is:  
 
x Clarity 
x Added value 
x Benefit / measure of value 
x Attribution / granularity 
x Consistency over time  
x Measurability / timeliness  
x Validity  
 
Table 5 shows how the published criteria sets reviewed in Section 4 and those suggested at the 
workshop map to the seven criteria. Each of these is discussed below.  
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Table 5: List of seven criteria, and cross mapping with existing quality indicator criteria sets 
Criterion Wording AHRQ 2008 NCHOD 2005 HSCIC 2014 Workshop criteria 
Clarity An indicator should be specific, stating clearly what is 
being measured, how it is measured and its 
interpretation. 
 SC1 
M1 
SP1, SP7 
1. Clarity 
4. Construction (a) 
5. Interpretation 
Clarity 
Appropriately defined area 
of activity 
Not ambiguous 
Unidirectional 
Added value The indicator should capture elements of quality not 
captured elsewhere.  
Construct validity 
Application 
 2. Rationale (e, g) 
6. Risks (a, c) 
 
Benefit / 
Measure of 
value  
The indicator should capture aspects of quality proven to 
be valued by users of health services. 
Face validity P1 
M7 
2. Rationale (a, e, f) Value / relevant  to patient 
Value to clinicians 
Inform patient 
safety/improvement 
Attribution / 
Granularity 
The indicator should measure aspects of quality that can 
be attributed to healthcare settings and that are subject 
to health system control. 
Face validity 
Fosters real quality 
improvement 
P2 
M2, M8, M9 
4. Construction (b, c, d) 
5. Interpretation (i) 
Coverage and 
comprehensiveness at 
national level 
Granularity - adjustable to 
different target 
populations, settings and 
to specific use 
Consistency 
over time  
The indicator should measure quality aspects 
consistently over time, at least annually, and in a timely 
manner. 
 M4, M5, M6 3.Data (d) 
 
Consistency over time 
Measurability 
/ Timeliness  
The quality aspect should be measurable / quantifiable. Precision M3 3.Data (e) Timeliness 
 
Validity  The indicator measures what it intends to measure, i.e. it 
is a discriminates between good and bad quality, is not 
subject to large variation due to random changes in 
small numbers of events, and minimises potential bias.   
Precision 
Minimum bias 
Construct validity 
 
SC2, SC3 
P3 
SP2, SP3, SP4, SP5, SP6 
4. Construction (a  W 
reproducibility; (e, f  W risk 
adjustment; uncertainty) 
5. Interpretation (d, 
sensitivity; e, caveats)  
6. Risks 
Specificity 
Sensitivity 
Ability to capture 
meaningful change 
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4.1 Clarity  
Clarity 
An indicator should be specific, stating clearly what is being measured, how it is measured and its 
interpretation. 
 
The need for an indicator to be clearly defined is a logical necessity, and two published criteria sets 
include this property. The HSCIC set focuses on the clarity of what is measured, covering the 
ŝŶĚŝĐĂƚŽƌ ?ƐŶĂŵĞ ?ĚĞƐĐƌŝƉƚŝŽŶ ?ŵĞĂƐƵƌĞŵĞŶƚƵŶŝƚƐ ?ĂŶĚƐĐŽƉĞ ? ? ? ?ŝƚƐĐŽŶƐƚƌƵĐƚŝŽŶ ? ?Ă ? ? and 
interpretation (5). The NCHOD matrix requires indicators to have an explicit definition, using 
appropriate statistical units and clinical terminology (SC1), an explicit methodology (M1), the 
appropriate unit of analysis (SP1) and a clear interpretation (SP7). The AHRQ set does not specify the 
need for clarity.  
 
Workshop participants stressed that indicators should clearly state the purpose for which the 
indicators are to be used. Further, workshop participants stated that indicators should satisfy 
specific statistical properties, such as being unidirectional and able to deal with volatility of the data. 
 
4.2. Added value 
Added value 
The indicator should capture elements of quality not captured elsewhere. 
 
dŚĞE,KĐƌŝƚĞƌŝĂĚŽŶŽƚŝŶĐůƵĚĞƚŚĞŶŽƚŝŽŶŽĨ ‘ĂĚĚĞĚǀĂůƵĞ ? ?,^/ƐƉĞĐŝĨŝĞƐƚŚĂƚĂŶŝŶĚŝĐĂƚŽƌ
ƐŚŽƵůĚĨŝůůĂŶƵŶŵĞƚŶĞĞĚŽƌ ‘ŐĂƉ ? ? ?Ğ ? ?ĂŶĚŝƚƐƌŽůĞǁŝƚŚŝŶƚŚĞƉĞƌĨŽƌŵĂŶĐĞĨƌĂŵĞǁŽƌŬƐŚŽƵůĚďĞ
ũƵƐƚŝĨŝĞĚ ? ?Ő ? ?Ă ?Đ ? ?,ZYĂĚĚƌĞƐƐĞƐ ‘ĂĚĚĞĚǀĂůƵĞ ?ƵŶĚĞƌƚŚĞŚĞĂĚŝŶŐ ‘ĂƉƉůŝĐĂƚŝŽŶ ? ?dŚŝƐĐĂƉƚƵƌĞƐƚŚĞ
ŶĞĞĚĨŽƌĂƐŝŶŐůĞŝŶĚŝĐĂƚŽƌƚŽ ‘ǁŽƌŬǁĞůů ?ǁŝƚŚŽƚŚĞƌŝŶĚŝĐĂƚŽƌƐŝŶĂƉĞƌĨŽƌŵĂŶĐĞĨƌĂŵĞǁŽƌŬ ?ƐŽƚŚĂƚ
together they provide a fuller picture of quality.  
 
dŚĞŝĚĞĂŽĨ ‘ĂĚĚĞĚǀĂůƵĞ ?ŝƐŵŽƌĞŝŵƉŽƌƚĂŶƚĨŽƌƉƵƌƉŽƐĞŽĨŽutput measurement than it might be 
for construction and reporting of quality indicators for assessing performance. This is because the 
ŽƵƚƉƵƚŵĞĂƐƵƌĞƐŚŽƵůĚďĞĚĞƐŝŐŶĞĚƚŽĐĂƉƚƵƌĞĐŽŵƉƌĞŚĞŶƐŝǀĞůǇƚŚĞďƵŶĚůĞŽĨĞĂĐŚƉƌŽĚƵĐƚ ?Ɛ
characteristics but needs to miŶŝŵŝƐĞƚŚĞƌŝƐŬŽĨ ‘ĚŽƵďůĞ-ĐŽƵŶƚŝŶŐ ?ƚŚĞƐĞĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐǁŚĞƌĞǀĞƌ
possible.  
 
In order to evaluate the risk of double-counting, the entire set of candidate quality measures needs 
to be jointly assessed, rather than considered in isolation. If two partially overlapping indicators are 
both to be incorporated in the output measure, there needs to be careful thought about what 
relative value to assign to each of these when they are combined so that their distinct contributions 
are accurately captured.  
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4.3 Benefit / Measure of value 
Benefit / Measure of value 
The indicator should capture aspects of quality proven to be valued by society. 
 
All three published ĐƌŝƚĞƌŝĂƐĞƚƐŝŶĐůƵĚĞƚŚŝƐĐŽŶĐĞƉƚ ?dŚĞ,^/ƐĞƚƐƉĞĐŝĨŝĞƐƚŚĂƚƚŚĞŝŶĚŝĐĂƚŽƌ ?Ɛ
rationale should refer to the sponsor (2a), providers (2e) and policy makers (2f). The NCHOD matrix 
ŝŶĐůƵĚĞƐƉŽůŝĐǇƌĞůĞǀĂŶĐĞ ? ‘ƉƵďůŝĐŝŶƚĞƌĞƐƚ ? ?W ? ?ĂŶĚƐƚ ŬĞŚŽůĚĞƌĂĐĐĞƉƚĂďŝůŝƚǇ ?D ? ? ?ZĞůĞǀĂŶƚ
stakeholders include users (patients), commissioners, providers and policy makers  W the public 
ĂŶĚ ?ŽƌƚĂǆƉĂǇĞƌƐĐŽƵůĚĂůƐŽďĞŝŶĐůƵĚĞĚ ?dŚĞ,ZYĐƌŝƚĞƌŝŽŶŽĨ ‘&ĂĐĞǀĂůŝĚŝƚǇ ?ŝŶĐůƵĚĞƐƚŚĞŶĞĞĚĨŽƌ
a sound clinical or empirical rationale.   
 
Workshop participants agreed on the importance of this criterion, stressing that indicators should 
capture aspects of quality that are valued by and relevant to patients (or by clinicians and other 
patient representatives, in recognition of the agency relationship in healthcare). 
 
Here again, there is divergence between the published criteria and those required for national 
accounting purposes. The national accounting measure of health output is supposed to capture the 
social value of what the health service produces. This means that output should reflect the value 
that society places on the activities of the health system. Hence, the scope of this criterion is 
perhaps more focused than that expressed in other criteria sets.  
 
4.4 Attribution / granularity 
Attribution / granularity 
The indicator should measure aspects of quality that can be attributed to healthcare settings and 
that are subject to health system control. 
 
An indicator is unsuitable as a measure of the quality of health care output if it represents a 
phenomenon outside the control or influence of the health system. All three criteria sets 
ŝŶĐŽƌƉŽƌĂƚĞĚƚŚŝƐŝĚĞĂĞǆƉůŝĐŝƚůǇ ?,ZYĐůĂƐƐŝĨŝĞƐƚŚŝƐĐŽŶĐĞƉƚƵŶĚĞƌŝƚƐ ‘&ĂĐĞǀĂůŝĚŝƚǇ ?ĐƌŝƚĞƌŝŽŶ ?
specifying that an indicator should be subject to provider or healthcare system control. Also in the 
,ZYƐĞƚ ? ‘&ŽƐƚĞƌƐƌĞĂůƋƵĂůŝƚǇŝŵƉƌŽǀĞŵĞŶƚ ?ĐŽǀĞƌƐ genuine engagement and the need to minimise 
incentives for gaming behaviours.  
  
/ŶƚŚĞ ‘ĐŽŶƐƚƌƵĐƚŝŽŶ ?ƐĞĐƚŝŽŶŽĨŝƚƐĐƌŝƚĞƌŝĂ ?,^/ƌĞƋƵŝƌĞƐŝŶĚŝĐĂƚŽƌƐƚŽďĞĨŝƚĨŽƌƉƵƌƉŽƐĞ ? ?ď ? ?ƚĂŬĞ
account of chance (4c) and be sensitive to changes in true events (4d).  Another relevant HSCIC 
criterion is the ability of healthcare providers to improve their performance (5i); HSCIC also suggests 
that there should be some guidance alongside the indicator that specifies the steps that 
commissioners and providers need to take.  
 
dŚĞE,KŵĂƚƌŝǆƵƐĞƐƚŚĞƚĞƌŵ ‘ĂĐƚŝŽŶĂďŝůŝƚǇ ?ƚŽĚĞƐĐƌŝďĞƉƌŽǀŝĚĞƌĐĂƉĂĐŝƚǇƚŽƉŽƐŝƚŝǀĞůǇŝŶĨůƵĞŶĐĞ
the indicator ĂŶĚƐŽ ‘ŝŶĚƵĐĞĂĨƵƚƵƌĞŚĞĂůƚŚ ?ĐŽƐƚďĞŶĞĨŝƚ ? ?W ? ? ?ƚƚƌŝďƵƚĂďŝůŝƚǇŝƐŽŶĞŽĨƚŚĞŵĂƚƌŝǆ ?Ɛ
methodological criteria (M2) as are measurability (M8) and cost-effectiveness (M9). These last two 
concepts underscore the need for provider engagement in designing the indicator, to ensure that 
the measurement process is feasible and affordable. 
 
Workshop participants also stressed that, for this criterion, there should be clarity about what is 
attributable to the actions of different parts of the health system. For example, the health system as 
a whole might contribute to improved life expectancy, but these improvements reflect the combined 
efforts of different parts of the health system, not just hospitals or primary care acting in isolation. 
Participants suggested that indicators of healthcare quality should be adjustable to specific uses and 
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settings and for different target populations. For instance, indicators should be capable of 
disaggregation to different units of analysis, eg national versus Trust level productivity 
measurement. These sentiments imply the need for a common set of process and outcome 
indicators, to be collected in relevant healthcare settings.  
 
Also, it was suggested that attribution is much more problematic when considering outcome 
measures than process measures of the quality of healthcare. This is because health outcomes are 
often determined by wider social factors and not only (or, often, even primarily) by healthcare 
utilisation. Ideally the contributions of these wider determinants would be captured in other parts of 
the national accounts. For example, the beneficial influences on health of improvements in the 
housing ƐƚŽĐŬŽƵŐŚƚƚŽďĞĐĂƉƚƵƌĞĚŝŶƚŚĞŵĞĂƐƵƌĞŽĨŚŽƵƐŝŶŐ ?ƐĐŽŶƚƌŝďƵƚŝŽŶƚŽ'W ? 
 
In summary, for national accounting purposes, it is important that the output measure captures the 
valuable characteristics and consequences of healthcare activities, not of other sectors of the 
economy.  
 
4.5 Consistency over time  
Consistency over time  
The indicator should measure quality aspects consistently over time. 
 
Usually quality measures are constructed so as to monitor progress over time, and this is more easily 
accomplished if the indicators are measured in a consistent fashion from one period to the next. 
Similarly in national accounting, the objective is not merely to measure the level of output at any 
particular point in time but to measure changes in output over time. 
 
The ARHQ criteria do not explicitly include the need for an indicator to measure quality consistently 
over time. In contrast, the HSCIC criteria specify the importance of both the frequency and 
timeliness of data available to calculate the indicator (3d). The NCHOD matrix differentiates three 
aspects of timeliness: the reporting frequency (M4), whether the indicator captures longitudinal 
changes in quality (M5) and whether other time-varying factors can be recognised and adjusted for 
(M6).  
  
Workshop participants also said it was important that indicators should be measured on a timely and 
consistent basis. 
 
The requirement for consistency over time is less demanding for national accounting purposes than 
it is for reporting of quality measures, where consistent definitions are required in order to construct 
ĂƚŝŵĞƐĞƌŝĞƐ ?ƵƚŝŶŶĂƚŝŽŶĂůĂĐĐŽƵŶƚŝŶŐĂůŽŶŐƚŝŵĞƐĞƌŝĞƐŝƐƵƐƵĂůůǇĐŽŶƐƚƌƵĐƚĞĚĂƐĂ ‘ĐŚĂŝŶŝŶĚĞǆ ? ?
The links in the chain only require that outputs are measured in a consistent fashion across two 
successive periods. If there are definitional changes, the chain index requires that outputs are 
measured using both old and new definitions in the period that the change occurs, so that a link to 
both the past and the future can be constructed.  
 
Timeliness of a quality indicator is also very important for the purposes of NHS output and 
productivity measurement, as series updates are usually conducted on an annual basis. Therefore, it 
is vital that quality indicators are available within the same timeframe. 
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4.6 Measurability / Timeliness 
Measurability / Timeliness  
The quality aspect should be measurable / quantifiable, at least annually, and in a timely manner. 
 
Whilst accepting the adage that what matters and what can be measured are not necessarily the 
same, any quality indicator has to be based on the measurable. All three criteria sets incorporate this 
ƌĞƋƵŝƌĞŵĞŶƚ ?ǁŝƚŚ,^/ƐƵŵŵĂƌŝƐŝŶŐƚŚĞĐŽŶĐĞƉƚĂƐƚŚĞŶĞĞĚĨŽƌĚĂƚĂƚŽďĞĂǀĂŝůĂďůĞĂŶĚ “ƌŽďƵƐƚ
enough to support the measure ĂŶĚŝƚƐĚĞƌŝǀĂƚŝŽŶƐ ? ? ?Ğ ? ?dŚŝƐĂůƐŽĂƉƉůŝĞƐĨŽƌŶĂƚŝŽŶĂůĂĐĐŽƵŶƚŝŶŐ
purposes. 
 
Workshop participants also suggested that indicators of healthcare quality should be comprehensive 
at the national level and available on a timely basis. 
 
4.7 Validity  
Validity  
The indicator measures what it intends to measure.   
 
For the purposes of constructing a national measure of healthcare output, the quality measure 
needs to be valid. More fully, it needs to be able to discriminate between good and bad quality, is 
not subject to large variation due to random changes in small numbers of events, and minimises 
potential bias. All three of the published criteria sets reviewed in Section 4 stated that indicators 
needed to satisfy one or other conceptualisation of validity. 
 
Workshop participants also stressed the importance of both specificity and sensitivity and the ability 
ŽĨĂŶǇŝŶĚŝĐĂƚŽƌƚŽĐĂƉƚƵƌĞ ‘ŵĞĂŶŝŶŐĨƵůĐŚĂŶŐĞ ? ?
 
If the output measure is to be employed sub-nationally, perhaps to understand and manage 
performance of healthcare organisations, then additional considerations of sensitivity and specificity 
might need to be considered. Sensitivity concerns the ability of the indicator to detect true positive 
values and specificity its ability to detect true negative values. Typically there is a trade-off between 
sensitivity and specificity (i.e. improved sensitivity might entail lower specificity).  
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5. Do published indicators satisfy the criteria? 
5.1 Introduction 
The final objective of this work was to assess the extent to which published indicators of the quality 
of healthcare satisfy the seven criteria, with the aim of finding indicators for potential use in the NHS 
output measure. We focussed on the NHS Outcome Framework (OF) indicators and the NHS Safety 
Thermometer indicators, which are summarised in the section 5.2. A full summary of each of the 
NHS Outcomes Framework and the NHS Thermometer indicators is provided in Appendix B.  
 
The review of the indicators against the seven criteria was performed as an individual task by 
members of the research team, and also by two experts, one from the DH and one from ONS.  
 
Each reviewer was provided with an excel spreadsheet set up as a matrix listing all NHS Outcome 
Framework (OF) indicators / NHS Safety Thermometer indicators against the seven criteria on which 
to record. Reviewers were asked to indicate whether or not they thought the indicator satisfied each 
criterion, whether an indicator should be included in the NHS output index and to select an 
appropriate NHS setting (Main and secondary) to which they thought the indicator related to. A 
blank box was also added for reviewers to record any comments they might have.  
 
The excel spreadsheet also contained an instructions sheet and a Criteria & definition sheet. To ease 
the reviewing process, each reviewer was sent a document including a brief summary of the criteria 
selection process, a summary of the published criteria set and a summary of the seven criteria 
identified by the research team. Reviewers were also sent a summary of all NHS OF indicators and 
NHS Safety Thermometer indicators, providing information about the definition, purpose and data 
availability for each indicator. Reviewers were asked to complete the exercise as an individual task. 
Completed spreadsheets were collected and collated, and summary tables produced, these being 
summarised in section 5.3. 
 
5.2 Published indicators 
NHS Outcomes Framework Indicators 
The NHS Outcomes Framework (OF) Indicators were developed in December 2010 with the aim of 
providing national accountability for the outcomes delivered by the NHS. Its objective is threefold: to 
be a driver of transparency, of improvement in the quality of care and of measurement of the 
outcomes produced by the NHS. The focus is on improving health and reducing health inequalities. 
The NHS OF delineates national outcomes goals, which are then used to monitor the progress of the 
NHS in England. 8 
 
NHS OF indicators are grouped ŝŶĨŝǀĞĚŽŵĂŝŶƐ ?ǁŚŝĐŚůŝƐƚƚŚĞ “ŚŝŐŚ-level national outcomes that the 
E,^ƐŚŽƵůĚďĞĂŝŵŝŶŐƚŽŝŵƉƌŽǀĞ ?.9 Each domain has a number of overarching indicators and a 
number of improvement areas.  
  
                                                        
8 https://beta.digital.nhs.uk/publications/ci-hub/nhs-outcomes-framework (last accessed 6th March 2018) 
9 https://beta.digital.nhs.uk/publications/ci-hub/nhs-outcomes-framework (last accessed 6th March 2018) 
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The five domains are: 
 
Domain 1 - Preventing people from dying prematurely 
This domain captures how successful the NHS is in reducing the number of avoidable deaths. 
 
Domain 2 - Enhancing quality of life for people with long-term conditions 
This domain captures how successfully the NHS is supporting people with long-term conditions to 
live as normal a life as possible. 
 
Domain 3 - Helping people to recover from episodes of ill health or following injury 
This domain captures how people recover from ill health or injury and wherever possible how these 
can be prevented. 
 
Domain 4 - Ensuring that people have a positive experience of care 
This domain looks at the importance of providing a positive experience of care for patients, service 
users and carers. 
 
Domain 5 - Treating and caring for people in a safe environment and protecting them from avoidable 
harm 
This domain explores patient safety and its importance in terms of quality of care to deliver better 
health outcomes.  
 
All indicators are calculated separately and where possible by local authority (both lower tier and 
upper tier), region, age, gender, sexual orientation, ethnicity, religion, deprivation decile and 
condition. 
 
NHS Thermometer Indicators 
The NHS Safety Thermometer is the measurement tool for a programme of work to improve patient 
safety. Indicators were collected and reported by NHS Digital from 2012/13 until April 2017. Since 
then, the NHS South, Central and West Commissioning Support Unit (SCW) has been managing the 
collection and publication of NHS Thermometer indicators on behalf of NHS Improvement.  
 
The NHS Thermometer indicators are used to record patient harms at the frontline, and to provide 
immediate information and analyses for frontline teams to monitor their performance in delivering 
harm free care, thereby leading to the reduction and, hopefully, elimination of, harm. Patients are 
assessed in the setting in which they receive care.  
 
The first indicators were introduced in 2012/13 and covered four areas, which were specifically 
relevant to older people who, experiencing more healthcare intervention, were more at risk of 
multiple harms. The four areas are:  
 
x Pressure ulcers 
x Falls 
x Urinary tract infections (UTIs) in patients with a catheter 
x New venous thromboembolisms (VTEs) 
 
dĂŬĞŶƚŽŐĞƚŚĞƌ ?ƚŚĞƐĞŝŶĚŝĐĂƚŽƌƐĂƌĞĂůƐŽŬŶŽǁŶĂƐƚŚĞ ‘ĐůĂƐƐŝĐ ?E,^thermometer. These four harms 
ǁĞƌĞƉƌŝŽƌŝƚŝƐĞĚĨŽƌĂƚƚĞŶƚŝŽŶďǇƚŚĞĞƉĂƌƚŵĞŶƚŽĨ,ĞĂůƚŚ ?ƐYƵĂůŝƚǇ ?/ŶŶŽǀĂƚŝŽŶ ?WƌŽĚƵĐƚŝǀŝƚǇĂŶĚ
Prevention (QIPP) Safe Care programme because they are common, and because there is a clinical 
consensus that they are largely preventable through appropriate patient care. The concept of a 
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ĐŽŵƉŽƐŝƚĞŵĞĂƐƵƌĞ ?,Ăƌŵ&ƌĞĞĂƌĞ ?ǁĂƐĚĞƐŝŐŶĞĚƚŽďƌŝŶŐĨŽĐƵƐƚŽƚŚĞƉĂƚŝĞŶƚ ?ƐŽǀĞƌĂůů
experience.   
 
Subsequently patient safety indicators were developed for other areas of health care, namely: 
 
x Maternity care10 
x Medication11 
x Mental Health services12 
x ŚŝůĚƌĞŶĂŶĚzŽƵŶŐWĞŽƉůĞƐ ?ƐĞƌǀŝĐĞƐ 
 
The box below reports the types of potential harms about which indicators are collected under these 
four broad areas. 
 
Maternity Care 
 
 Maternal Infection 
 Perineal Trauma 
 Post-Partum Haemorrhage 
 Term babies Apgar score 
 Term baby treatment [no data 
presented] 
 tŽŵĞŶ ?ƐƉĞƌĐĞƉƚŝŽŶŽĨƐĂĨĞƚǇ 
 
Medication  
 
 Medication Reconciliation (MR) 
 Allergy status 
 Medication omission 
 Omissions of Critical Medication  
 Identifying harm from high risk 
medicines 
Mental Health services 
 
 Self-harm 
 Psychological safety 
 Whether a victim of violence or 
aggression 
 Omissions of medication 
 Restraint (inpatients only) 
 
ŚŝůĚƌĞŶĂŶĚzŽƵŶŐWĞŽƉůĞ ?ƐƐĞƌǀŝĐĞƐ 
 
 Deterioration  
 Extravasation 
 Pain 
 Skin Integrity 
 
 
 
Data for all five NHS Safety Thermometer indicators are collected on a single day each month. They 
enable wards, teams and organisations to understand the burden of harm to patients (the elderly, 
women and babies, the mentally ill, children and young people) and of medication error. Data can be 
used as a baseline to direct improvement efforts and then to measure improvement over time. 
 
5.3 Results of the review 
NHS Outcomes Framework Indicators 
Tables 6 to 15 summarise the results of the reviewing process. For each indicator-criterion 
combination, we report the total number of reviewers who answered that the particular indicator 
satisfies a criterion over the total number of reviewers who have provided an answer. For example, 
                                                        
10 The Maternity Safety Thermometer was first piloted between June 2013 and October 2014 and is now fully released. 
11 The Medication Safety Thermometer was designed to identify harm from medication error in line with the Domain 5 of 
the NHS Outcomes Framework. 
12 The Mental Health Safety Thermometer was tested in a pilot phase from Nov 2012 until May 2013, and a number of 
changes were made to the collection over that period of time. A second period of pilot testing and further development 
ran from the end of April 2014 to October 2014. The official launch of the Mental Health Safety Thermometer took place 
on the 23rd of October 2014. 
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in Table 6 only 2 out of 5 reviewers thought that ƚŚĞE,^K&ŝŶĚŝĐĂƚŽƌ “Life expectancy at 75  W 
Males ? ƐĂƚŝƐĨŝĞĚƚŚĞ “ĚĚĞĚǀĂůƵĞ ?ĐƌŝƚĞƌŝŽŶ ? 
 
To facilitate the visual identification of indicators that satisfy a certain criterion, indicator-criterion 
combinations have been colour-coded, with darker blue shades indicating a higher agreement 
amongst reviewers on whether or not an indicator satisfies a criterion. 
 
NHS OF indicators pertaining to Domain 1 (Table 6) refer to the prevention of premature (avoidable) 
deaths. Reviewers thought that these did not usually ƐĂƚŝƐĨǇƚŚĞ “ĚĚed ǀĂůƵĞ ?ĐƌŝƚĞƌŝŽŶand that 
there were problems with  “ttribution ? to the health care system. The former was found to be the 
ĐĂƐĞĨŽƌĂůŵŽƐƚĂůůŝŶĚŝĐĂƚŽƌƐ ?ǁŚŝůƐƚƚŚĞůĂƚƚĞƌǁĂƐƚƌƵĞĨŽƌ “>ŝĨĞĞǆƉĞĐƚĂŶĐǇ ?ďŽƚŚDĂůĞƐĂŶĚ
Females and disease specific under 75 mortality rates and excess under 75 mortality rate. 
 
For NHS OF indicators designed to capture the quality of life of individuals with long-term conditions 
(Domain 2) (Table 7), reviewers agreed that most indicators satisfied all or almost all seven criteria. 
For five indicator-criterion combinations, a number of exceptions were found as follows: the 
indicator  “ƐƚŝŵĂƚĞĚĚŝĂŐŶŽƐŝƐƌĂƚĞĨŽƌƉĞŽƉůĞǁŝƚŚĚĞŵĞŶƚŝĂ ?was found not to meet the criterion 
 “ĞŶĞĨŝƚ ?DĞĂƐƵƌĞŽĨǀĂůƵĞ ?; the indicators  “ŵƉůŽǇŵĞŶƚŽĨƉĞŽƉůĞǁŝƚŚůŽŶŐ-ƚĞƌŵĐŽŶĚŝƚŝŽŶƐ ? and 
 “ŵƉůŽǇŵĞŶƚŽĨƉĞŽƉůĞǁŝƚŚŵĞŶƚĂů ŝůůŶĞƐƐ ? did not satisfy the criterion  “ƚƚƌŝďƵƚŝŽŶ ?; the indicator 
 “,ĞĂůƚŚ-related quality of life for people with long-ƚĞƌŵĐŽŶĚŝƚŝŽŶƐ ? did not satisfy the criteria 
 “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ? ĂŶĚ “Measurability/timeliness ? ?ƚŚĞŝŶĚŝĐĂƚŽƌ “WƌŽƉŽƌƚŝŽŶŽĨpeople feeling 
ƐƵƉƉŽƌƚĞĚƚŽŵĂŶĂŐĞƚŚĞŝƌĐŽŶĚŝƚŝŽŶ ? did not meet the criteria  “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ? and 
 “Measurability/timeliness ? ?ĂŶĚĨŝŶĂůůǇƚŚĞŝŶĚŝĐĂƚŽƌ “,ĞĂůƚŚ-related quality of life for people with 
three or more long-ƚĞƌŵĐŽŶĚŝƚŝŽŶƐ ? did not satisfy the criterion  “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ?. 
 
For Domain 3 NHS OF indicators (Table 8), most reviewers agreed that almost all indicators met all 
seven criteria. However, for four indicators for which issues were raised on either their ability to add 
value, their Consistency over time, or the possibility to attribute the performance measured to the 
ǁŽƌŬŝŶŐƐŽĨƚŚĞŚĞĂůƚŚĐĂƌĞƐǇƐƚĞŵ ?dŚĞƐĞǁĞƌĞ “ŵĞƌŐĞŶĐǇreadmissions within 30 days of 
ĚŝƐĐŚĂƌŐĞ ? ? “WƌŽƉŽƌƚŝŽŶŽĨŽůĚĞƌƉĞŽƉůĞ ? ? ?ĂŶĚŽǀĞƌ ?ǁŚŽǁĞƌĞƐƚŝůůĂƚŚŽŵĞ ? ?ĚĂǇƐĂĨƚĞƌĚŝƐĐŚĂƌŐĞ
from hospital into reablement/rehabilitation services ? ĂŶĚ “dŽŽƚŚĞǆƚƌĂĐƚŝŽŶƐĚƵĞƚŽĚĞĐĂǇĨŽƌ
children admitted as inpatienƚƐƚŽŚŽƐƉŝƚĂů ?ĂŐĞĚ ? ?ǇĞĂƌƐĂŶĚƵŶĚĞƌ ? ? 
 
NHS OF indicators designed to assess whether patients, service users and carers have a positive 
experience of care (Domain 4, Table 9) were also found to be either failing to add value or lacking 
consistency over time. Note that not all reviewers provided an answer as to whether or not the 
ŝŶĚŝĐĂƚŽƌƐƐĂƚŝƐĨŝĞĚƚŚĞ “ĚĚĞĚǀĂůƵĞ ?ĐƌŝƚĞƌŝŽŶĂŶĚ, of those who did, about 50% thought that it did 
so.  
 
Scores for the NHS OF indicators relating to the safe treatment and care of patients (Domain 5) are 
shown in Table 10. Reviewers felt that these indicators met most criteria, though some questioned 
whether they  “dded value ?. 
 
Overall, reviewers found for the NHS OF indicators that if these did not meet a criterion, this was 
most likely due to a failure to satisfy eŝƚŚĞƌƚŚĞ “ĚĚĞĚǀĂůƵĞ ?ŽƌƚŚĞ “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ?
criterion. Reviewers found the criteria most likely ƚŽďĞƐĂƚŝƐĨŝĞĚǁĞƌĞ “ůĂƌŝƚǇ ? ?
 “Measurability/timeliness ?ĂŶĚ “sĂůŝĚŝƚǇ ? ? 
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Table 6: NHS OF Domain 1: Review of selected criteria set 
Domain 1 
Preventing people from dying prematurely 
Clarity 
Added 
value 
Benefit/Measure 
of value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability
/timeliness 
Validity 
Indicator               
Potential Years of Life Lost (PYLL) from causes considered 
amenable to healthcare  ? Adults 
6/6 2/4 6/6 4/6 6/6 6/6 6/6 
Potential Years of Life Lost (PYLL) from causes considered 
amenable to healthcare - Children and Young People 
6/6 2/4 6/6 4/6 6/6 6/6 6/6 
Life expectancy at 75  ? Males 6/6 2/5 5/6 1/6 6/6 6/6 4/5 
Life expectancy at 75  ? Females 6/6 2/5 5/6 1/6 6/6 6/6 4/5 
Neonatal mortality and stillbirths 6/6 1/4 6/6 5/6 6/6 6/6 6/6 
Under 75 mortality rate from cardiovascular disease 6/6 2/5 6/6 2/5 5/6 6/6 6/6 
Under 75 mortality rate from respiratory disease 6/6 2/5 6/6 3/5 5/6 6/6 6/6 
Under 75 mortality rate from liver disease 6/6 2/5 6/6 2/5 5/6 6/6 6/6 
Under 75 mortality rate from cancer 6/6 1/4 6/6 2/5 5/6 6/6 6/6 
One-year survival from all cancers 6/6 0/5 6/6 6/6 5/6 6/6 6/6 
Five-year survival from all cancers 6/6 0/4 6/6 6/6 4/5 6/6 6/6 
One-year survival from breast, lung and colorectal cancer 6/6 1/5 6/6 6/6 5/6 6/6 6/6 
Five-year survival from breast, lung and colorectal cancer 6/6 1/5 6/6 6/6 4/5 6/6 6/6 
Excess under 75 mortality rate in adults with serious 
mental illness 
6/6 1/4 6/6 2/5 5/6 5/6 5/6 
Infant mortality 6/6 2/5 6/6 4/5 6/6 6/6 6/6 
Five-year survival from all cancers in children 6/6 1/4 6/6 5/6 4/5 6/6 6/6 
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Table 7: NHS OF Domain 2: Review of selected criteria set 
Domain 2 
Enhancing quality of life for people with long-term conditions 
 Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability
/timeliness 
Validity 
Indicator               
Employment of people with long-term conditions 6/6 4/5 6/6 0/5 5/6 5/6 5/5 
Health-related quality of life for people with long-term 
conditions 
5/6 5/5 6/6 4/5 2/6 2/6 4/6 
Unplanned hospitalisation for asthma, diabetes and epilepsy in 
under 19s 
5/6 4/5 4/6 6/6 5/6 6/6 6/6 
Proportion of people feeling supported to manage their 
condition 
4/6 3/5 4/6 3/6 2/6 2/6 4/5 
Unplanned hospitalisation for chronic ambulatory care 
sensitive conditions (all ages) 
4/6 4/5 4/6 5/6 6/6 6/6 6/6 
Employment of people with mental illness 4/6 4/5 5/6 0/5 5/6 5/6 6/6 
Estimated diagnosis rate for people with dementia 4/6 3/5 1/6 6/6 4/6 5/6 4/6 
Health-related quality of life for people with three or more 
long-term conditions 
4/6 3/5 6/6 4/5 2/6 5/6 4/6 
Health-related quality of life for carers 3/6 3/5 5/6 4/6 4/6 4/6 5/6 
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Table 8: NHS OF Domain 3: Review of selected criteria set 
Domain 3 
Helping people to recover from episodes of ill health or 
following injury 
 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability
/timeliness 
Validity 
Indicator               
Hip fracture: Proportion of patients recovering to their 
previous levels of mobility at 30 days 
6/6 3/4 6/6 6/6 3/6 4/6 6/6 
Hip fracture: Proportion of patients recovering to their 
previous levels of mobility at 120 days 
6/6 4/4 6/6 4/6 3/6 5/6 6/6 
Emergency readmissions within 30 days of discharge from 
hospital 
5/6 5/5 6/6 6/6 6/6 6/6 6/6 
Emergency admissions for children with lower respiratory 
tract infections 
5/6 2/4 4/6 4/6 6/6 6/6 6/6 
Proportion of older people (65 and over) who were still at 
home 91 days after discharge from hospital into 
reablement/rehabilitation services 
5/6 3/4 6/6 3/6 3/6 5/6 4/6 
Proportion offered rehabilitation following discharge from 
acute or community hospital 
5/6 2/4 5/6 4/6 2/6 5/6 5/6 
Tooth extractions due to decay for children admitted as 
inpatients to hospital, aged 10 years and under 
5/6 3/4 4/5 2/5 5/6 6/6 5/6 
Emergency admissions for acute conditions that should not 
usually require hospital admission 
4/6 3/4 5/6 5/6 6/6 6/6 5/6 
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Table 9: NHS OF Domain 4: Review of selected criteria set 
Domain 4 
Ensuring that people have a positive experience of care 
 Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability
/timeliness 
Validity 
Indicator               
GP out-of-hours services 6/6 3/4 6/6 6/6 2/6 5/6 5/6 
Patient experience of hospital care 6/6 2/3 5/6 5/6 5/6 5/6 5/6 
Patient experience of outpatient services 6/6 2/4 6/6 6/6 1/6 5/6 5/6 
Patient experience of A&E services 6/6 2/4 5/6 6/6 0/6 5/6 6/6 
Patient experience of primary care - GP services 5/6 2/4 6/6 6/6 3/6 5/6 5/6 
ZĞƐƉŽŶƐŝǀĞŶĞƐƐƚŽŝŶƉĂƚŝĞŶƚƐ ?ƉĞƌƐŽŶĂůŶĞĞĚƐ 5/6 1/3 5/6 3/6 3/4 3/6 2/3 
Access to GP services 5/6 2/4 6/6 6/6 2/6 5/6 6/6 
Access to NHS dental services 5/6 2/4 6/6 5/6 2/6 5/6 6/6 
tŽŵĞŶ ?Ɛexperience of maternity services 5/6 2/4 6/6 5/6 0/6 5/6 5/6 
Bereaved carers' views on the quality of care in the last 3 
months of life 
5/6 2/4 6/6 3/6 0/6 2/5 2/6 
Patient experience of community mental health services 5/6 2/4 5/6 5/6 1/4 5/6 4/5 
NHS dental services 3/6 2/4 5/6 5/6 2/4 3/4 3/4 
 
Table 10: NHS OF Domain 5: Review of selected criteria set 
Domain 5 
Treating and caring for people in a safe environment and 
protecting them from avoidable harm 
 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability
/timeliness 
Validity 
Indicator               
Deaths from VTE related events within 90 days post discharge 
from hospital 
6/6 4/4 6/6 3/5 6/6 6/6 6/6 
Incidence of healthcare-associated infection - MRSA 
bacteraemia 
6/6 3/4 6/6 6/6 6/6 6/6 6/6 
Incidence of healthcare-associated infection - C.difficile 6/6 3/4 6/6 6/6 6/6 6/6 6/6 
Admission of full-term babies to neonatal care 5/6 2/4 5/6 5/6 4/6 6/6 4/6 
Patient safety incidents reported 4/6 2/4 5/6 5/6 1/6 3/6 2/6 
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NHS Thermometer Indicators 
The first set of NHS Safety Thermometer indicators in Table 11 ƌĞůĂƚĞƚŽƚŚĞ ‘ůĂƐƐŝĐ ?thermometer. 
dŚĞŵĂũŽƌŝƚǇŽĨƌĞǀŝĞǁĞƌƐĨŽƵŶĚƚŚĂƚƚŚŝƐƐĞƚŽĨŝŶĚŝĐĂƚŽƌƐĚŝĚŶŽƚƐĂƚŝƐĨǇƚǁŽĐƌŝƚĞƌŝĂ P “ĚĚĞĚǀĂůƵĞ ?
and  “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ?, whilst agreeing, in some cases unanimously that they satisfied the 
remaining criteria.  
 
Regarding the indicators measuring harm caused by medication errors (Table 12), all six reviewers 
ĂŶƐǁĞƌĞĚƚŚĂƚƚŚĞŝŶĚŝĐĂƚŽƌƐƐĂƚŝƐĨŝĞĚƚŚĞ “ůĂƌŝƚǇ ? ? “ĞŶĞĨŝƚ ?DĞĂƐƵƌĞŽĨǀĂůƵĞ ?ĂŶĚƚŚĞ
 “Attribution ?ĐƌŝƚĞƌŝĂ ?KŶůǇŽŶĞƌĞǀŝĞǁĞƌŝŶĚŝĐĂƚĞĚƚŚĂƚƚŚĞƐĞŝŶĚŝĐĂƚŽƌƐƐĂƚŝƐĨŝĞĚƚŚĞ “ŽŶƐŝƐƚĞŶĐǇ
ŽǀĞƌƚŝŵĞ ?ĐƌŝƚĞƌŝŽŶ ?^ŝŵŝůĂƌůǇ ?ĨŽƌƚŚĞ “ĚĚĞĚǀĂůƵĞ ?ĐƌŝƚĞƌŝŽŶ ?ƌĞǀŝĞǁĞƌƐǁĞƌĞŐĞŶĞƌĂůly satisfied 
that the Medication Safety indicators satisfied this particular criterion. Regarding both the 
 “Measurability/timeliness ?ĂŶĚ “sĂůŝĚŝƚǇ ?ĐƌŝƚĞƌŝĂ ?ƚŚĞŵĂũŽƌŝƚǇŽĨƌĞƐƉŽŶĚĞŶƚƐĂŐƌĞĞĚƚŚĂƚƚŚĞ
criteria were met by the indicators. 
 
Reviewers in general did not find that the NHS Mental Health Safety Thermometer indicators (Table 
13) satisfied ƚŚĞ “ĚĚĞĚǀĂůƵĞ ? ? “ƚƚƌŝďƵƚŝŽŶ ?  ?ĞǆĐĞƉƚĨŽƌƚŚĞŝŶĚŝĐĂƚŽƌƐ ‘WƌŽƉŽƌƚŝŽŶŽĨƉĂƚŝĞŶƚƐƚŚĂƚ
ŚĂǀĞŚĂĚĂŶŽŵŝƐƐŝŽŶŽĨŵĞĚŝĐĂƚŝŽŶŝŶƚŚĞůĂƐƚ ? ?ŚŽƵƌƐ ?ĂŶĚ ‘WƌŽƉŽƌƚŝŽŶŽĨƉĂƚŝĞŶƚƐƚŚĂƚŚĂǀĞďĞĞŶ
ƌĞƐƚƌĂŝŶĞĚŝŶƚŚĞůĂƐƚ ? ?ŚŽƵƌƐ ?ĂŶĚƚŚĞ “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ “ĐƌŝƚĞƌŝĂ ?&Žƌ these criteria, the 
reviewers either did not provide an answer at all or did not find that a particular indicator met the 
criterion. For the remaining criteria, the majority of reviewers agreed that they were met by the 
indicators. 
 
NHS Safety Thermometer indicators assessing the safety of healthcare services delivered to 
maternity care patients (mothers and babies) were found to satisfy in general all criteria (some with 
unanimous agreement amongst reviewers), except for the criterion  “ŽŶƐŝƐƚĞŶĐǇŽǀĞƌƚŝŵĞ ? for 
which only one reviewer found them to satisfy it.  
 
A similar outcome to the one that emerged from the reviewing process for the Maternity services 
appeared for the last set of NHS Safety Thermometer indicators, namely the Children and Young 
People indicators. 
 
Overall, we found general agreement among reviewers that NHS Thermometer indicators were most 
likely to be excluded from further consideration because reviewers felt that the indicator either 
failed to add value or lacked consistency over time. Reviewers found that most indicators met the 
remaining criteria. 
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Table 11: NHS Safety Thermometer - Classic: Review of selected criteria set 
Classic 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability/
timeliness 
Validity 
Indicator               
Pressure Ulcers 4/6 1/3 6/6 6/6 1/5 5/6 6/6 
Falls 4/6 1/3 6/6 5/6 1/5 5/6 5/6 
VTE 5/6 0/3 6/6 5/6 1/5 5/6 6/6 
Catheters 5/6 1/3 6/6 6/6 1/5 5/6 6/6 
 
Table 12: NHS Safety Thermometer - Medication: Review of selected criteria set 
Medication 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability/
timeliness 
Validity 
Indicator               
Proportion of patients with reconciliation started within 24 hours 
of admission 6/6 2/4 6/6 6/6 1/4 5/6 5/5 
Proportion of patients who have had an omitted dose in the last 
24 hours 6/6 2/5 6/6 6/6 1/5 5/6 5/5 
Proportion of patients with medicine allergy status documented 6/6 3/5 6/6 6/6 1/4 5/6 5/5 
Proportion of patients with an omission of a critical medicine 6/6 3/5 6/6 6/6 1/5 5/6 5/5 
Proportion of patients receiving a high risk medication in the last 
24 hours 6/6 3/5 6/6 6/6 1/4 5/6 5/6 
Proportion of patients on a high risk medicine that trigger an 
MDT referral 6/6 3/5 6/6 6/6 1/3 6/6 4/4 
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Table 13: NHS Safety Thermometer  ? Mental Health: Review of selected criteria set 
Mental health 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability/
timeliness 
Validity 
Indicator               
Proportion of patients that have self-harmed in the last 72 hours 5/6 1/4 6/6 0/4 1/5 5/6 4/5 
Proportion of patients that feel safe at the point of survey 6/6 1/4 5/6 0/4 1/5 5/6 4/5 
Proportion of patients that have been the victim of 
violence/aggression (last 72 hours) 
5/6 1/4 5/6 0/4 1/5 5/6 4/5 
Proportion of patients that have had an omission of medication 
in the last 24 hours 
6/6 2/4 6/6 4/5 1/5 5/6 5/6 
Proportion of patients that have been restrained in the last 72 
hours 
4/6 1/4 5/6 3/5 1/4 6/6 3/4 
 
Table 14: NHS Safety Thermometer - Maternity: Review of selected criteria set 
Maternity 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability/
timeliness 
Validity 
Indicator               
Proportion of women that had a maternal infection 6/6 2/5 6/6 5/6 1/5 5/6 5/6 
Proportion of women that had a 3rd/4th degree perineal trauma 6/6 4/5 6/6 6/6 1/5 5/6 6/6 
Proportion of women that had a PPH of more than 1000mls 6/6 4/5 6/6 6/6 1/5 5/6 6/6 
Proportion of Term Babies with an Apgar less than 7 at 5 Minutes 6/6 4/5 6/6 4/5 1/5 5/6 6/6 
Proportion of women who were left alone at a time that worried 
them 
6/6 3/5 6/6 6/6 1/5 5/6 6/6 
Proportion of women with concerns about safety during labour 
and birth not taken seriously 
5/6 3/5 6/6 6/6 1/5 5/6 6/6 
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Table 15: NHS Safety Thermometer  ? Children and Young People: Review of selected criteria set 
Children and Young People 
Clarity 
Added 
value 
Benefit/ 
Measure of 
value 
Attribution/ 
granularity 
Consistency 
over time 
Measurability/
timeliness 
Validity 
Indicator               
Proportion of patients with an EWS not completed for each set 
of observations in the last 12 hours 
5/6 2/5 5/6 5/6 1/5 5/6 5/6 
Proportion of patients with an EWS completed, triggered and not 
escalated 
5/6 2/5 5/6 5/6 1/5 5/6 5/6 
Proportion of patients with extravasation in the last 24 hours 6/6 2/5 6/6 6/6 1/5 5/6 6/6 
Proportion of patients in pain at the point of survey 6/6 2/5 6/6 6/6 1/5 5/6 6/6 
Proportion of patients with a pressure ulcer (new or old) 6/6 3/5 6/6 6/6 1/5 5/6 6/6 
Proportion of patients with a moisture lesion (new or old) 6/6 3/5 6/6 6/6 1/5 5/6 6/6 
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5.4 Which indicators met most criteria? 
We draw the preceding material to identify those indicators that satisfy the greatest number of 
criteria. In performing this assessment, the seven criteria are afforded equal weight. This simplifies 
the task but also reflects the views expressed by UK experts at the workshop. 
 
Given that reviewers expressed different views on whether indicators satisfied each criterion, we set 
thresholds about how much agreement there had to be among reviewers. The strictest threshold 
required that, for an indicator to be considered, 80% of the reviewers had to have said that all 
criteria were satisfied by the indicator in question. We also report how many indicators would be 
selected if the threshold was progressively relaxed to 70%, 60% and 50% consensus levels. 
 
Only one NHS Outcomes Framework indicator met the strictest cut-off rule (80% of consensus), 
three indicators met the 70% cut-off rule, 8 indicators met the 60% cut-off rule and finally 17 
indicators met the 50% cut-off rule. A summary of these indicators can be found in Appendix A. 
 
Of these 17, two NHS OF indicators pertain to Domain 1, three indicators pertain to Domain 2, five 
indicators pertain to Domain 3, three indicators pertain to Domain 4 and six indicators pertain to 
Domain 5. We show the selected indicators in the Venn-Diagram in Figure 2. 
 
No NHS Thermometer indicators could be selected based on any of the above cut-off rules. 
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Figure 2: Venn Diagram of selected NHS Outcomes Framework indicators based on different cut-off rules 
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6. Conclusions 
A measure of the output of the health system should capture the value of the output produced. This 
is challenging because people usually do not demand healthcare for its own sake, but because of its 
contribution towards improving their health. Capturing the value of healthcare therefore requires 
some means of measuring both the outcome and process of healthcare delivery.  
 
Current practice in accounting for the quality of healthcare services makes use of routinely available 
information in order to capture the QALYs associated with treating patients, by combining 
information on survival rates, life expectancy and a measure of change in health status before and 
after treatment. The process of care delivery is captured by measures of treatment waiting times. 
 
This approach may overlook other important characteristics of the quality of healthcare. This review 
was designed to assess whether other indicators of quality could be incorporated into the NHS 
output measure. To this end, the review aimed first to identify which criteria an indicator ought to 
satisfy in order to be considered for inclusion in an output measure.  
 
To this end we evaluated three published sets of criteria developed by national bodies responsible 
for assessing healthcare system performance. We sought the opinions of UK experts on quality 
expressed at the workshop. From this process seven criteria were established, these being: 
 
x Clarity 
x Added value 
x Benefit / measure of value 
x Attribution / granularity 
x Consistency over time  
x Measurability / timeliness  
x Validity  
 
We next reviewed two sources of quality indicators currently collected and reported for the English 
NHS: the NHS Outcomes Framework indicators and NHS Thermometer indicators. A schema, 
including indicator name and source, data source, time period covered, definitions and purpose, was 
developed for each of the indicators. Each indicator was assessed by the research team, and one 
expert from the Department of Health and one from the Office for National Statistics in order to 
establish whether they met each of the identified criteria. Depending on the level of consensus 
among reviewers, a maximum of 17 indicators were short-listed for potential use as quality adjustors 
for NHS output, all of which are NHS Outcomes Framework indicators. These potential indicators, 
ordered according to those best judged to have met the criteria, were: 
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Threshold Indicator 
80% Emergency readmissions within 30 days of discharge from hospital 
70% Incidence of healthcare associated infection  W MRSA bacteraemia;  
Incidence of healthcare associated infection  W C.difficile 
60% Unplanned hospitalisation for chronic ambulatory care sensitive conditions; 
Unplanned hospitalisation for asthma, diabetes and epilepsy in under 19s; 
Emergency admissions for acute conditions that should not usually require 
hospital admission;  
Patient experience of hospital care; 
Deaths from venous thromboembolism (VTE) related events within 90 days post 
discharge from hospital 
50% Potential Years of Life Lost (PYLL) from causes considered amenable to healthcare 
 W Adults; 
Potential Years of Life Lost (PYLL) from causes considered amenable to healthcare 
 W Children and Young people; 
Health-related quality of life for carers; 
Hip fracture: proportion of patients recovering to their previous levels of mobility / 
walking ability at 30 days; 
Hip fracture: proportion of patients recovering to their previous levels of mobility / 
walking ability at 120 days; 
Proportion of older people (65 and over) who were still at home 91 days after 
discharge from hospital into reablement/rehabilitation services; 
Patient experience of primary care  W GP services; 
Patient experience of dental services; 
Admission of full-term babies to neonatal care   
 
Further research is needed to establish how best to incorporate the set of indicators in the NHS 
output measure. The main challenge will be to establish what weight (value) should be attached to 
each quality dimension so that it can be incorporated in the overall output measure. 
 
Overall, we recommend that sensitivity analyses are performed for the selected indicators in order 
to establish whether their effects on the NHS output growth measure are in line with prior 
expectations as well as to ensure consistency of the NHS output measure over time.  
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Appendix A: Summary of selected NHS Outcomes Framework indicators 
Domain 1 
Overreaching Indicators 
Indicator: Potential Years of Life Lost (PYLL) from causes considered amenable to 
healthcare - Adults 
Source:  
 
Data source:  
 
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
ONS avoidable mortality / ONS populations / ONS period and cohort life 
expectancy  
Years covered: 2009-2014 
Recent changes: N/A 
 
Definition 
The number of years of life lost by every 100,000 adults aged 20 and over dying from a condition 
which is usually treatable, measured in a way which allows for comparisons between populations 
with different age profiles and over time. 
 
Purpose 
To ensure that the NHS is held to account for doing all that it can to prevent amenable deaths. 
ĞĂƚŚƐĨƌŽŵĐĂƵƐĞƐĐŽŶƐŝĚĞƌĞĚ ‘ĂŵĞŶĂďůĞ ?ƚŽŚĞĂůƚŚĐĂƌĞĂƌĞƉƌĞŵĂƚƵƌĞĚĞĂƚŚƐƚŚĂƚƐŚŽƵůĚŶŽƚ
occur in the presence of timely and effective healthcare. 
 
 
 
Figure A1: Directly age and sex standardised potential years of life lost (PYLL) per 100,000 registered 
patients, 95% confidence intervals (CI) 
 
Comments: 
Although the values change over time, the absolute difference is very small and very unlikely to 
make any difference.  
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Domain 1 
Overreaching Indicators 
Indicator: Potential years of life lost (PYLL) from causes considered amenable to healthcare 
- children and young people 
Source:  
 
Data source:  
 
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
ONS avoidable mortality / ONS populations / ONS period and cohort life 
expectancy  
Years covered: 2003-2014 
Recent changes: Retired in the 2015/16 NHS Outcomes Framework 
 
Definition 
The number of years of life lost by every 100,000 persons aged 0 to 19 dying from a condition 
which is usually treatable, measured in a way which allows for comparisons between populations 
with different age profiles and over time. 
 
Purpose 
To ensure that the NHS is held to account for doing all that it can to prevent amenable deaths. 
ĞĂƚŚƐĨƌŽŵĐĂƵƐĞƐĐŽŶƐŝĚĞƌĞĚ ‘ĂŵĞŶĂďůĞ ?ƚŽŚĞĂůƚŚĐĂƌĞĂƌĞƉƌĞŵĂƚƵƌĞĚĞĂƚŚƐƚŚĂƚƐŚŽƵůĚŶŽƚ
occur in the presence of timely and effective healthcare. 
 
 
 
Figure A2: Potential years of life lost (PYLL) from causes considered amenable to healthcare - children and 
young people 
 
Comments: 
Bigger variation than for adults, but in absolute number the difference will not make an impact on 
our index. 
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Domain 2 
Improvement areas: Reducing time spent in hospital by people with long-term conditions 
Indicator: Unplanned hospitalisation for chronic ambulatory care sensitive conditions 
Source:  
 
Data source:  
 
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
HES / ONS populations 
Years covered: 2003/04-2015/16 
Recent changes: N/A 
 
Definition 
This indicator measures how many people with specific long-term conditions, which should not 
normally require hospitalisation, are admitted to hospital in an emergency. These conditions 
include, for example, diabetes, epilepsy and high blood pressure. 
 
Purpose 
This outcome is concerned with how successfully the NHS manages to reduce emergency 
admissions for all long-term conditions where optimum management can be achieved in the 
community. 
 
 
 
Figure A3: Directly age and sex standardised rate of unplanned hospital admissions 
 
Comments 
The indicator has changed over the years it has been measured, but the year-on-year differences, 
especially in the last financial years, are small. 
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Domain 2 
Improvement areas: Reducing time spent in hospital by people with long-term conditions 
Indicator: Unplanned hospitalisation for asthma, diabetes and epilepsy in under 19s 
Source:  
 
Data source:  
NHS Outcomes Framework 
(last accessed8 Jun 2017) 
HES / ONS populations 
Years covered: 2003/04-2015/16 
Recent changes: N/A 
 
Definition 
This indicator measures how many young people (aged 0-18 inclusive) who have asthma, diabetes 
or epilepsy are admitted to hospital in an emergency. 
 
Purpose 
This outcome is concerned with how successfully the NHS manages to reduce avoidable 
emergency admissions for children with asthma, diabetes or epilepsy. These three conditions 
were chosen as they account for around 94 per cent of emergency admissions for children (under 
19s) with long-term conditions. 
 
  
 
Figure A4: Directly age and sex standardised rate of unplanned hospital admissions for asthma, diabetes and 
epilepsy in under 19s 
 
Comments 
The indicator has changed over the years it has been measured, but the year-on-year differences, 
especially in the last financial years, are small. 
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Domain 2 
Improvement areas: Enhancing quality of life for carers 
Indicator: Health-related quality of life for carers 
Source:  
 
Data source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
GPPS 
Years covered: 2011/12-2015/16 (July to March) 
Recent changes: N/A 
 
Definition 
This indicator measures health-related quality of life for people who identify themselves as 
helping or supporting family members, friends, neighbours or others with their long-term physical 
or mental illness/disability or because of problems related to old age. 
 
Purpose 
This indicator seeks to capture how successfully the NHS is supporting carers to live as normal a 
life as possible. This indicator helps people understand whether health-related quality of life for 
carers is improving over time. 
 
 
 
Figure A5: Average adjusted health status (EQ- ? ? ?ƐĐŽƌĞĨŽƌŝŶĚŝǀŝĚƵĂůƐƌĞƉŽƌƚŝŶŐƚŚĂƚƚŚĞǇĂƌĞĐĂƌĞƌƐ ?ĂŐĞĚ
18 and above, based on responses to a question from the GP Patient Survey 
 
Comments 
No variation over time, the indicator has practically constant values. Informal care might come under 
social services as opposed to the NHS.  
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Domain 3 
Improvement areas: Improving recovery from fragility fractures 
Indicator: Hip fracture: Proportion of patients recovering to their previous levels of 
mobility / walking ability at 30 days 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
The National Hip Fracture Database (NHFD)) 
Years covered: 2011 to 2015 (calendar year) 
Recent changes: N/A 
 
Definition 
This indicator measures the proportion of patients, expressed as a percentage, with a hip fracture 
recovering to their previous levels of mobility at 30 days. 
 
Purpose 
This indicator aims to measure how effectively people recover their mobility following a hip 
fracture. 
 
 
 
Figure A6: Proportion of patients recovering to their previous levels of mobility/walking ability at 30 days 
 
Comments 
Value of indicator has increased significantly between 2013 and 2015. Shortcoming: only four data 
points are available. 
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Domain 3 
Improvement areas: Improving recovery from fragility fractures 
Indicator: Hip fracture: Proportion of patients recovering to their previous levels of 
mobility / walking ability at 120 days 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
The National Hip Fracture Database (NHFD)) 
Years covered: 2011 to 2015 (calendar year) 
Recent changes: N/A 
 
Definition 
This indicator measures proportion of patients, expressed as a percentage, with a hip fracture 
recovering to their previous levels of mobility at 120 days. 
 
Purpose 
This indicator aims to measure how effectively people recover their mobility following a hip 
fracture. 
 
 
 
Figure A7: Proportion of patients recovering to their previous levels of mobility/walking ability at 120 days 
 
Comments 
Value of indicator has been increased significantly (10.3 percentage points) between 2013 and 2015. 
Shortcoming: only four data points are available. 
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Domain 3 
Overreaching Indicators 
Indicator: Emergency readmissions within 30 days of discharge from hospital 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Hospital Episode Statistics (HES), Admitted Patient Care (APC) 
Years covered: 2002/03  W 2011/12 
Recent changes: N/A 
 
Definition 
This indicator measures the percentage of admissions of people who returned to hospital as an 
emergency within 30 days of the last time they left hospital after a stay. Admissions for cancer 
ĂŶĚŽďƐƚĞƚƌŝĐƐĂƌĞĞǆĐůƵĚĞĚĂƐƚŚĞǇŵĂǇďĞƉĂƌƚŽĨƚŚĞƉĂƚŝĞŶƚ ?Ɛcare plan. 
 
Purpose 
This indicator aims to measure the success of the NHS in helping people to recover effectively 
from illnesses or injuries. If a person does not recover well, it is more likely that they will require 
hospital treatment again within the 30 days following their previous admission. Thus, 
readmissions are widely used as an indicator of the success of healthcare in helping people to 
recover. 
 
 
 
Figure A8: Percentage of Emergency admissions occurring within 30 days of last previous discharge from 
hospital. Indirectly standardised rate (excl. cancer and obstetrics), 95% confidence intervals (CI) 
 
Comments 
Indicator has gradually increased over the time series. The overall increase between 2002/03 and 
2011/12 is equal to 24.3 percentage points. 
The indicator is currently on hold due to a methodological review.  
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Domain 3 
Overreaching Indicators 
Indicator: Emergency admissions for acute conditions that should not usually require 
hospital admission 
Source:  
 
Data source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Hospital Episode Statistics (HES), Admitted Patient Care (APC) 
Years covered: 2003/04-2015/16 
Recent changes: N/A 
 
Definition 
The indicator measures the number of emergency admissions to hospital in England for acute 
conditions such as ear/nose/throat infections, kidney/urinary tract infections and heart failure, 
among others, that could potentially have been avoided if the patient had been better managed 
in primary care. 
 
Purpose 
This indicator aims to measure the reduction in emergency admissions for conditions that should 
usually be managed outside hospital. Where an individual has been admitted for one of these 
conditions, it may indicate that they have deteriorated more than should have been allowed by 
the adequate provision of healthcare in primary care or as a hospital outpatient. 
 
 
 
Figure A9: Emergency admissions for acute conditions that should not usually require hospital admission 
 
Comments 
Indicator has increased significantly over the time period considered. The overall increase in this 
indicator of emergency admissions is just under 6 per cent between 2003/04 and 2015/16. 
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Domain 3 
Improvement areas: Helping older people to recover their independence after illness or injury 
Indicator: Proportion of older people (65 and over) who were still at home 91 days after 
discharge from hospital into reablement/rehabilitation services 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Short and Long-Term Data Return (SALT) and Hospital Episode Statistics (HES) 
Years covered: 2011/12-2015/16 (financial years?  W not indicated) 
Recent changes: N/A 
 
Definition 
This indicator measures the proportion of older people (aged 65 and over), expressed as a 
percentage, who, after a period of reablement/rehabilitation, maintain their independence by 
remaining or returning to their home or previous residence 91 days after leaving hospital. 
 
Purpose 
This indicator measures the benefit to individuals from reablement, intermediate care and 
rehabilitation following a hospital episode, by determining whether an individual remains living at 
home 91 days following discharge. This is seen as a key outcome for many people using 
reablement services. 
 
 
 
Figure A10: Proportion of older people (65 and over) who were still at home 91 days after discharge from 
hospital into reablement/rehabilitation services Add figure and text 
 
Comments 
Very small change over the four year period. Shortcoming: only five data points are available. 
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Domain 4 
Overreaching Indicators 
Indicator: Patient experience of GP services 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
GP Patient Survey (GPPS) from Ipsos MORI (http://www.gp-patient.co.uk)  W 
Official Statistics 
Years covered: 2011/12-2015/16 (financial year  W period coverage July to September of 
previous year and January to March of following year for the respective financial 
year) 
Recent changes: N/A 
 
Definition 
This indicator measures the weighted percentage of people who report their overall experience 
ŽĨ'WƐĞƌǀŝĐĞƐĂƐ ‘ĨĂŝƌůǇŐŽŽĚ ?Žƌ ‘ǀĞƌǇŐŽŽĚ ? ? 
 
Purpose 
This indicator aims to capture the experience of patients of their GP. The vast majority of the 
population visit their GP each year and often it is the experience people have of primary care that 
determines their overall view of the NHS. 
 
 
 
Figure A11: Weighted percentage of people reporting  ?fairly good ? or  ?very good ? overall experience of  
GP services 
 
Comments 
Small but significant decreases in each of the last three years, before picking up in the last year of 
the survey.  
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Domain 4 
Overreaching Indicators 
Indicator: Patient experience of dental services 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
GP Patient Survey (GPPS) from Ipsos MORI (http://www.gp-patient.co.uk)  W 
Official Statistics 
Years covered: 2011/12-2015/16 (financial year  W period coverage July to September of 
previous year and January to March of following year for the respective financial 
year) 
Recent changes: N/A 
 
Definition 
This indicator measures the weighted percentage of people who report their overall experience 
ŽĨE,^ĚĞŶƚĂůƐĞƌǀŝĐĞƐĂƐ ‘ĨĂŝƌůǇŐŽŽĚ ?Žƌ ‘ǀĞƌǇŐŽŽĚ ? 
 
Purpose 
This indicator aims to capture the experience of patients of NHS dental services. 
 
 
 
Figure A12: Weighted percentage of people reporting  ?ĨĂŝƌůǇ good ? or  ?very good ? overall experience of NHS 
dental services 
 
Comments 
Time series shows small but significant increase of 2.2 percentage points from 2011/12 to 2015/16. 
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Domain 4 
Overreaching Indicators 
Indicator: Patient experience of hospital care 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
National Inpatient Survey provided by the Care Quality Commission  W Official 
Statistics. Published annually, available from Care Quality Commission (CQC) in 
April each year, although the 2014-15 survey was not released until May 2015 
due to the general election. 
Years covered: 2003/04-2015/16(financial year - Hospital stay 01/06 to 31/08; Survey collected 
01/09 to 31/01 of the respective year) 
Recent changes: N/A 
 
Definition 
Patient experience measured by scoring the results of a selection of questions from the National 
Inpatient Survey looking at a range of elements of hospital care. 
 
Purpose 
This indicator aims to capture the experience of patients who have received medical treatment in 
hospital. 
 
 
 
 
Figure A13: Average score of patients experience of hospital care  
Comments 
Value has fluctuated throughout the time series. Very little change from initial score in 2003/04. 
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Domain 5 
Improvement areas: Reducing the incidence of avoidable harm 
Indicator: Deaths from venous thromboembolism (VTE) related events within 90 days post 
discharge from hospital 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Hospital Episode Statistics (HES) - National Statistics. Linked HES-ONS Mortality 
Data. Both Health and Social Care Information Centre (HSCIC). 
Years covered: 2007/08-2015/16 (financial years) 
Recent changes: N/A 
 
Definition 
The indicator measures the number of patients who have been admitted to hospital with any 
cause and die within 90 days of their last discharge from a VTE related event, expressed as a rate 
per 100,000 adult hospital admissions. 
 
Purpose 
This indicator aims to measure the reduction in deaths from VTE related events by driving efforts 
to improve the prevention, detection and treatment of VTE before it causes death. 
 
 
 
Figure A14: Deaths from VTE related events within 90 days post discharge. Crude rate per 100,000 (adult) 
hospital admissions 
 
Comments 
Indicator value decreasing between 2007/08 and 2011/12, with a spike in 2012/13 before settling at 
pre-2011/12 figures. 
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Domain 5 
Improvement areas: Reducing the incidence of avoidable harm 
Indicator: Incidence of healthcare-associated infection - MRSA 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Mandatory Surveillance of Healthcare Associated Infections by Public Health 
England (PHE) 
Years covered: 2008/09-2015/16(Financial year) 
Recent changes: N/A 
 
Definition 
The number of Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections 
reported to Public Health England (PHE). 
 
Purpose 
This indicator aims to measure the progress in reducing the incidence of avoidable harm, 
specifically healthcare-associated MRSA infections. 
 
 
 
Figure A15: Crude count (Incidence) of all cases of MRSA blood stream infections reported 
 
Comments 
Large year on year decreases over the time series, a total reduction of 72percent from 2008/09. The 
pace of decrease is now slowing down. 
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Domain 5 
Improvement areas: Reducing the incidence of avoidable harm 
Indicator: Incidence of healthcare-associated infection - C. difficile 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 Jun 2017) 
Mandatory Surveillance of Healthcare Associated Infections by Public Health 
England (PHE) 
Years covered: 2007/08  W 2014/15 (financial year) 
Recent changes: N/A 
 
Definition 
The number of Clostridium difficile infections reported to Public Health England (PHE), in patients 
aged two years or older. 
 
Purpose 
This indicator aims to measure the progress in reducing the incidence of avoidable harm, 
specifically healthcare-associated C. difficile infections. 
 
 
 
Figure A16: Crude count (incidence) of all cases of C-difficile infections reported 
 
Comments 
Large year on year decreases since 2007/08 (start of the time series) until 2013/14, since 2014/15 
the number of C.difficile cases has started to increase. 
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Domain 5 
Improvement areas: Improving the safety of maternity services 
Indicator: Admission of full-term babies to neonatal care 
Source:  
 
Data Source:  
NHS Outcomes Framework 
(last accessed 8 June 2017) 
The total number of full-term babies (gestation greater than 36 weeks) based on 
birth registration information linked to birth notifications data from the Office 
for National Statistics (ONS). 
Years covered: 2010  W 2012 (calendar year) 
Recent changes: N/A 
 
Definition 
The number of full-term babies (gestation greater than 36 weeks) admitted within 28 days of 
birth to a neonatal unit, expressed as a percentage of all full-term births. 
 
Purpose 
This indicator aims to reduce the number of avoidable admissions of full-term babies to neonatal 
care and overall improve the safety of maternity services. 
 
 
 
 
Figure A17: Admission of full-term babies to neonatal care. Full-term neonatal episodes rate per 100 full-
term live births 
 
Comments 
Value appears to have increased slightly  W interpret with caution, as the increase might be due to 
more admissions being reported rather than occurring. 
Shortcoming: Only three data points are available. 
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